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Nitric oxide (NO) and carbon monoxide (CO), over the past several decades, have been 
considered as toxic gases, which are environmentally damaging or deadly to humans and animals 
at high concentrations.[1-4] However, since 1990s they have been well established as the famous 
gaseous signaling molecules (gasotransmitters), displaying notable chemical reactivity, including 
hydrogen sulfide (H2S). [1] They are considered as messenger molecules that have diverse 
functions on and are involved in numerous bioregulatory pathways. Various animal models have 
demonstrated that these labile biological mediators diffuse into adjacent cells to interact with their 
targets, to reduce leukocyte adherence in the blood vessels, to be anti-inflammatory and to reduce 
blood vessel restenosis. [1-6] Thus, an appropriate amount of gasotransmitters delivery can lead to 
positive effects on inflammation and wound healing, which attracts considerable therapeutic 
interest. [2–4] This chapter will separately introduce the biological identities and activities of 
molecule species in organism systems. A brief description of the mechanism of species (NO or 
CO) and species donors during the process of releasing signal molecules on targeted sites will be 
given. The term “donor” implies that the compound releases the active mediator. Accordingly, 
these donors that release desired quantity of NO or CO to cells and tissues are called nitric oxide 
releasing molecules (NORMs) or carbon monoxide releasing molecules (CORMs) can be 
developed as potential therapeutic agents. In addition, their development in recent progress will 
be presented and the discussion of relevant drugs (NORMs and CORMs) that release NO or CO 
under light triggered conditions will be clearly illustrated. Meanwhile, this section will also 
introduce the application of these chemical compounds that can be used for controlled drug 
delivery, which generally recognized as NO releasing materials (NORMAs) or CO releasing 





1.1. Nitric oxide and its generation from NO releasing molecules 
1.1.1. The biological activities of nitric oxide  
Nitric oxide (NO) was long thought of as a simple, common air pollutant, which is formed from 
the oxidation of nitrogen and incomplete combustion of gasoline, for instance in automobile 
exhaust fumes. However, in 1867, Thomas Lauder Brunton first reported the therapeutic use of 
exogenous NO prescribed to rapid relief of angina pectoris in ischemic patients, which 
surrounded considerable controversy and was not recognized at the time due to his incorrect 
interpretation of the background of angina pectoris. [5–8] Maseri et al. in 1977, concluded the 
explanations of the effects of nitrates presented by Lewis and Gorlin, and established that the 
drugs could release coronary spasm and dilate the peripheral venous capacitance vessels due to 
their capability of dilating the coronary vessels within an ischemic myocardial domain. [7] In the 
same year, Ferid Murad discovered that several nitro vasodilators improved guanylate cyclase 
activity in particulate and/or soluble preparations from various tissues. Furthermore, he 
speculated that the generation of free NO from the decomposition of these agents also increased 
guanylate cyclase activity and cyclic guanosine monophosphate levels in intact tissues. [9] Robert 
Francis Furchgott believed that blood vessels were dilated because a new concept endothelium-
derived relaxing factor (EDRF), which was probably produced by endothelial to relax vascular 
smooth muscle cells. Louis José Ignarro, together with and independently of Furchgott, concluded 
that EDRF was identical to NO. [10–14] This was the first discovery that a gas can act as a signal 
molecule in the organism. Interest in NO grew rapidly, consequently, research in various fields 
has implicated that this substance is involved in multiple physiological processes, including in the 
blood pressure regulation, mediation of specific cytotoxicity apoptosis, the inhibition of platelet 
aggregation, neurotransmission, and immune stimulation. [2,15–19] Hence, the Nobel Prize in 
Physiology or Medicine was awarded to Furchgott, Ignarro and Murad for their discoveries 
concerning “nitric oxide as a signaling molecule in the cardiovascular system”.  
The whole biochemistry process of NO in vivo can be divided into three stages: generation, 
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react which formed from the reaction of oxygen or superoxide with NO exerted medium effects. 
The former, generally, happen at low NO concentrations (< 0.2 μM), as well as the indirect 
effects involve in at higher concentrations of NO (> 0.4 μM). [37,40,41]  
The first described physiological target for NO was soluble guanylyl cyclase (sGC), an enzyme 
that converts guanosine triphosphate (GTP) into the cyclic guanosine monophosphate (cGMP). 
[22,42,43] NO binds to the iron site within the heme moiety of guanylyl cyclase to facilitate a 
conformational change that results in enzyme activation. Another major direct effect of NO is 
interaction with cytochrome P450 (CYP), a family of enzymes that are involved in the synthesis 
and catabolism of numerous biomolecules in species ranging from bacteria through to plants and 
mammals. [44–46] Binding of NO to the heme can prevent oxygen binding leading to a reversible 
inhibiting catalysis or irreversible inhibition (indirect effect). Furthermore, the direct effects also 
conclude reactions of NO with some metal complexes, free radicals and lipid peroxidation at near 
diffusion rates.   
In another pathway, NO may undergo various oxidative processing steps and can be converted to 
nitrogen oxide (NOx) species with formal N atom oxidation states ranging from +1 to +5 before 
encountering a cellular target (equation 1−6).[47,48] Due to its unpaired electron, NO free radical 
(•NO) can react with molecular oxygen (O2), superoxide anion (O2-•) or transition metals to 
generate reactive nitrogen species (RNS): nitroxyl ions (NO-), nitrosonium cations (NO+), nitrite 
ions (NO2-), nitrate ions (NO3-), peroxynitrite (OONO-) or metal nitrosyl derivatives. [43,47,49–52] 
OONO- is a powerful oxidizing and nitrating species that causes many pathological events 
including cardiovascular and neurodegenerative diseases, inflammation and cancer. [33,38,53] 
Meanwhile, NO+ can react with nucleophilic centers such as ROH, RSH and RR’NH to produce 
RO-NO, RS-NO or RR’N-NO, consequently undergo other reactions to exert biological effects. 
In addition, •NO can also be converted to metal nitrosyl complex, some of which are better suited 
for delivery of NO or longer-term storage. [54,55] 
                                                                           (1) 





                                                                (3) 
                                                     (4) 
                                                         (5) 
                                                                                      (6) 
Finally, NO and NO derivatives play their roles through reactions with biomolecules in the action 
stage. Due to its radical character, NO interacts with large numbers of redox-active species, 
including targets composed of redox-active metals, redox-active metals that bound to or near 
redox-active ligands, redox-inactive metals which supported by redox-active ligands, or metal-
free organic species.   
1.1.2. Bonding of Nitric oxide in metal complexes 
Nitric oxide free radical, an uncharged molecule and an exceedingly weak Lewis base when act as 
a nucleophilic agent, presents molecular orbitals with different nitrogen and oxygen contributions 
because of the difference in the electronegativities of nitrogen and oxygen atoms. The highest 
occupied molecular orbital (HOMO) of nitric oxide radicals is half-filled therefore the singly 
occupied molecular orbital (SOMO) is used in the radical recombination reactions and represents 
the orbital in which an electron is removed or added in redox reactions which represented by the 
molecular orbital diagram of •NO (Figure 1.1). [40] The bonding molecular orbitals belong 
predominantly to oxygen, while all antibonding molecular orbitals belong predominantly to 
nitrogen. [36] Rooted in the combination of the 2s atomic orbitals, the two sigma molecular orbitals 
(σ1 and σ2*), generally do not participate in bonding orbitals. The σ2* orbital, having the more 
energetic antibonding, shows that the nitrogen nonbonding electron pair, nature of sigma bond, 
symmetrical characteristic and essential energy aspects of •NO. There also exists an unpaired 
electron in a π* molecular orbital polarized toward nitrogen in this molecule resides opposing the 
polarization of the lower energy πb orbitals. Due to the five electrons in the outermost shell, 
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from designed ligands can solve problems, other suitable transition metal alternatives have gained 
attention to develop in efforts.  
Generally, ruthenium complexes are more kinetically stable than their iron analogs. For this 
reason, ruthenium nitrosyls have received considerable attention in environmental remediation 
and in biomedical applications. [82,87] Initial research on the Ru–NO complexes started from 
compounds with simple ligands with the formula [Ru(NH3)4(X)(NO)]3+ (X = NH3, sulfite, 
pyridine, imidazole, salen and related salophen etc.), in which a ammine ruthenium specie 
precursor Ru(NH3)63+ which can produce Ru(NH3)5NO3+ was an important nitrosyl compound to 
study systematic mechanistic of metal–NO bond formation until the discovery that NO is a 
mammalian bioregulatory agent. [88–90] Ruthenium nitrosyls by far have been tried to incorporate 
into different types of polymeric materials or inorganic solids due to their inherent thermal 
stability. Mascharak and co-workers observed that dye molecules or conjugated fluorophore 
group can be directly coordinated to Ru centers in related ruthenium nitrosyls which even allows 
detection in solution via the fluorescence signaling. [91–93] Borovik et al. immobilized the 
ruthenium nitrosyl complexes by modifying the salen ligand to allow for copolymerization with a 
mesoporous ethylene glycol dimethylacrylate material. [94] Tfouni entrapped soluble complex 
[Ru(salen)(OH2)(NO)]+ in a porous silicate sol-gel to prepare an immobilized and regenerable NO 
source. [95] The great advantage of ruthenium complexes is their great stability over long periods 
of time under physiological conditions, while relatively low quantum yield for NO release and the 
in general requirement UV light for NO release are crucial disadvantages. Ongoing investigations 
are needed to overcome these critical limitations in order to prove to be suitable systems for 
applications as anticancer drugs in physical systems. [91,96–100] 
Commonly, the occurrence of transition metal complexes is Fe and Ru metals, however, to date 
more research have included Mn, Cu, Os, Ir, Au, Ni, Cr, Co and so on. [57,101–114] Overall, the 
applications of these materials with incorporated metal nitrosyls are appropriate and practical for 
investigating the roles of NO in biology area and need to be further studied.  





For treating relevant diseases, the nitric oxide releasing complexes must be contained in or 
incorporated with biocompatible materials so that NO can be transported to a designated local 
area and release NO selectively to targeted sites. As the half-life of nitric oxide is relatively short 
(in seconds), the release area of NO is normally confined to the region around where the NO 
donors are placed. [115] NO releasing materials are in general triggered by pH change, enzyme 
degradation, thermal or chemical variety, or photoinduction to elicit a desired response. [116–121] 
Photoactive NO releasing materials (photo-NORMs) have gained increasing attention because 
they can deliver NO under precise control (over the time, location and dosage) to selected 
biological targets by using light as an external medium and thereby can be explored as a new 
strategy of photodynamic therapy (PDT). Photo-NORMs must be stable in aqueous solutions in 
the dark and relatively non-toxic, the residue in the organism can be eliminated in an appropriate 
time interval. While the activity of photo NO donating complex must be triggered only by 
irradiation at a specific wavelength. Furthermore, photo-NORMs that can effectively release their 
cargo upon low intensity light exposure at long wavelengths are also beneficial to reduce tissue 
damage. In theory, the near-infrared (NIR) light which can penetration through mammalian tissue 
is primarily limited to the range of around 700–1000 nm, on the other hand, it happened high 
scattering in tissues when light longer than 800nm. [122,123] Metal nitrosyls complexes are desirable 
photo-responsive candidates because mostly of these complexes release NO by exposing to the 
light of various wavelengths. 
As mentioned above, iron–nitrosyl complexes usually lack stability and some of them have 
toxicity problems under physiological conditions, the issues of relatively low quantum yield for 
NO releasing and UV light triggered for ruthenium complexes are also needed to solve, as well as 
manganese compound has a limited stability in aqueous media. Plenty of strategies have been 
proposed to move forward with metal-NO complexes. A variety of metal nitrosyls coordinated 
with quinoline, pyridyl moiety, carboxamido-N or thiolato-S donors to be activated by longer 
visible wavelengths or near-infrared light and rapidly release NO under irradiation. [63,82,96,110,124,125] 
In physicality, large number of metal complexes were embedded in various structures, such as 
gels, thin films, polymer fibers, microparticles, and nanoparticles. [41,126–130] For example, Schiller 





solution in nanofibrous non-wovens with electrospinning to release NO into a biological 
environment upon low intensity illumination. [131] 
1.2. Carbon monoxide and its generation from CO releasing molecules 
1.2.1. The biological activities of carbon monoxide 
Carbon monoxide (CO), an odorless, colorless and tasteless but toxic gas which typically 
produced by insufficient oxygen, was described as “the silent killer” for a long time. Like NO, 
CO was recently considered as a signaling gas molecule in living organisms involving multiply of 
bioregulatory functions. Compared with O2, CO holds much more diffusion and affinity for 
hemoglobin which is oxygen-transport metalloprotein thereby easily generates 
carboxyhemoglobin (COHb) and ultimately is removed from respiratory organs. [132,133] The 
principal task of hemoglobin is to release oxygen which carries from the lung to provide energy 
for the metabolism process of the organism. When CO occupied more than 50 % of the total 
hemoglobin, it will inhibit aerobic respiration circulation by interfering with the oxygen-carrying 
ability subsequently leading to coma, respiratory depression or other fatal outcomes. [134,135] While 
at low concentrations, carbon monoxide exerts remarkable influences on tissues, such as 
vasodilatation, anti-inflammatory, inhibition of cell proliferation, neurotransmission and anti-
apoptosis, consequently can be used as a potential therapeutic agent for wound healing, organ 
transplant and cardiovascular diseases. [132,136–143] 
Exogenous carbon monoxide is primarily generated through incomplete oxidation of carbon-
containing compounds, while endogenous carbon monoxide (CO) is overwhelmingly generated 
by the heme physiological degradation reaction with the presence of heme oxygenase (HO) 
enzymes in mammalian cells. [144,145] There are three isozymes of HO with dissimilar tissue 
localization and distinct functions, which are respectively known as inducible isoform HO-1 and 
constitutive isoforms HO-2, HO-3. [146–150] HO-1 is a stress protein which exists in endoplasmic 
reticulum of tissues that respond to regulation by multiple stress stimulation and protects the cells 
from oxidative stress. HO-2 is mainly active in the vasculature and nervous system in the brain, 





homology with HO-2. Both HO-1 and HO-2 can participate in the reaction of heme catabolism in 
which the electrons are supplied by NADPH-dependent cytochrome reductase. In addition to CO, 
Fe2+-protoporphyrin IX (Heme) is broken down to ferrous iron ion (Fe2+) and biliverdin which is 
subsequently reduced to bilirubin by biliverdin reductase. The generated ferrous iron ions are 
converted into ferritin through binding protein and activation of iron response elements. [151–153] 
         
Scheme 1.2 The pathways of heme degradation and formation of carbon monoxide by heme oxygenase in 
vivo. 
Like NO, one of the main molecule targets of CO is to produce cyclic guanylyl cyclase (cGMP) 
by activating soluble guanylyl cyclase (sGC). CO associates with the histidine-ligated 
hemoprotein that have a pentacoordinate metal center in which the heme cofactor covalently 
bonded to iron via an axial histidine. [1,154] This action of CO is much weaker than that of NO due 
to the ability of NO that binding bursts with imidazole group in the heme molecule and 
subsequently Fe2+ exposure which CO doesn’t have. This corresponded to the dramatic bent hem 
and massive N-terminal subdomain shift proceeded by NO with fully activated state compared to 
the initial large hem pivot shift introduced by CO. [155] Another interaction of CO and sGC is 





reported to exhibit more critical signaling roles in anaerobic conditions than NO because of the 
limitation of NOS under hypoxic conditions.  [156] 
Another target to realize protective effect of CO involves regulation of various ion channels that 
activated by the changes of membrane potential and/or the increase of intracellular ions 
concentration. The most noticeable ion channels are potassium ions (K+) channels, which are also 
named as big potassium (BK) channels (Maxi-K or slo1), containing voltage-activated potassium 
channels (Kv), calcium-activated potassium channels (BKCa) and ATP-sensitive potassium 
channels (KATP). The stimulation of BK channels accelerates to stabilize of membrane potential 
and diminish cell activation resulting in relax vascular smooth muscle cells. [152,157] CO affects the 
L-type calcium ions (Ca2+) channels through inducing the generation of reactive oxygen species 
(ROS) that can interact with cysteines located on the C-terminal tail of Ca2+ channels. This 
inhibition of Ca2+ channels reduces the calcium ions influx and thereby can be applied in coronary 
heart disease. [158,159] Besides the K+ channels and Ca2+ channels, CO can also affect sodium ions 
(Na+) channels and other channels to conduct multifold functions. [160–162] After accomplishing its 
mission, around 80% of CO is exhaled through the lung with the form of COHb as well as a 
fraction of CO is oxidized to CO2 at a quite slow rate to be expelled from the organism.  
In addition, CO can interact with the metal ion in metalloclusters of specific microbial proteins 
through a haem-independent approach to complete the reversible oxidation of CO to CO2 in the 
global carbon cycle. [163]  
1.2.2. Bonding of carbon monoxide in metal complexes 
The possession of unpaired electrons of NO and the ability of chemically rearrange in aqueous 
solution for H2S help improve their chemical activities, unlike them, CO seems the least 
chemically reactive molecule and quite stable in biological systems. Carbon monoxide molecule 
is isoelectronic with nitrogen molecule (N2), cyanide ion (CN-) and nitrosonium cations (NO+), 
containing ten valence electrons which can be represented by the configuration 
(σ2s)2(σ*2s)2(π2p)4(σ2p)2 distributing over triple bond between carbon and oxygen atoms and one 
lone pair electrons on each of the atoms (:C≡O:). [164,165] The molecular orbital (MO) of CO (sp 
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molecular orbital on the CO which overlapped with filled d-orbitals of the metal. This process is 
called π back-donation, which weaken the carbon-oxygen bond as well as strengthen the carbon-
metal bond and support CO in acting as a Lewis acid. The extent of π back-donation will also 
affect the vibrational frequency of carbon-oxygen bond which can be reflected in IR spectrum. 
The characteristic vibrational frequencies in various bonding generally range from 1650 cm−1 to 
2200 cm−1, while the νCO of free carbon monoxide is usually found around 2143 cm−1. [170] In 
addition, within the M-C-O group, the carbon-oxygen bond is generally strong, whereas the 
carbon-metal is relatively weak. This contrasts with the metal nitrosyl complexes mentioned 
above where the nitrogen-oxygen bond is weak while the nitrogen-metal bond is relatively strong. 
The binding mode helps CO cleavage from metal complexes. 
1.2.3. Metal carbonyl coordination complexes for CO release 
Carbon monoxide releasing molecules are preferably constructed of transition metal carbonyl 
complexes with one or more CO ligands and possible ancillary ligand for many decades. They 
can be presented as a simple formula MxLy(CO)z, where M is the metal ion, L is coordinated 
ligand, as well as the stoichiometric coefficients x and z must be ≥1. When CORMs are triggered, 
CO will liberate from associated CO releasing molecules (equation 8). 
                             (8) 
From the point of therapeutic use, metal carbonyl complexes which involved this process must 
satisfy some essential requirements, such as reasonable solubility in aqueous solutions and 
stability for storage under ambient mediums (including aerobic conditions). Moreover, they and 
their metabolites after decomposition should be non-toxic or low-toxic and do not interact with 
biological systems.    
The first generation of CORMs was introduced by Motterlini et al. in 2002 and they studied the 
behaviors of three water-insoluble commercial metal carbonyls, iron pentacarbonyl (Fe(CO)5), 
dimanganese decacarbonyl (Mn2(CO)10, CORM-1), and tricarbonyldichlororuthenium (II) dimer 





cold light source over around 60 mins, however, Fe(CO)5 is highly toxic and is limited for further 
development. CORM-2 releases CO spontaneously through ligand exchange by forming a new 
bond with S in DMSO solution. Furthermore, to improve the solubility in water solution, 
tricarbonylchloro(glycinato) ruthenium (II) (Ru(CO)3Cl(NH2CH2COO), CORM-3) was 
developed and rapidly liberated CO in vivo biological models. [172] Besides triggered by ligand 
substitution, CORM-3 can also be driven by thermal degradation. CO will thermally dissociate 
from the metal complexes when heated, with the vacant site occupied by solvent ligand. The 
thermal strategy is basically used for the synthesis of simple metal carbonyls but is limited 
employed in physiological environment because of the contradictory attributes of activated 
temperature (approximated to room temperature) and the stability of initiators under such 
conditions.   
 
Figure 1.6 Selection of metal-based CORMs (X = halide, in italic: p =  photolysis, ΔT  =  thermal trigger, pH  
= pH change, E = enzyme trgger, o = oxidation and L = ligand substitution/exchange).  
Among the first generation of CORMs, the sodium boranocarbonate (Na2(H3BCO2), CORM-A1, 





liberated CO through two steps (protonation and hydrolysis) yielding H3B–CO which rapidly lost 
CO upon acidification. [173,174] What is more, its rate of CO release was negative correlated with 
pH value and the decomposition almost stopped at pH > 8.5. The pH dependent CORMs, 
commonly utilize strong π donor ligand (such as O2−, OH−, OR−, NH2− or NR2−) to free adjacent 
coordinated CO, and can be used in specific tissues. [169]  
Contrary to CORM-A1, Na[Mo(CO)3(histidinato)] (ALF186, Figure 1.6 f) release CO much 
faster in at neutral pH than in acidic conditions which was observed by the oral and 
intraperitoneal experiment. [175] This molecule is classified as an oxygen triggered CORM and 
ROS species are considered to promote the reaction. In fact, there also abundant dissolved 
molecular oxygen in living organisms which can be directly interacts with the metal atom 
resulting in the breakdown of existing M-CO bonds and subsequently CO release. Besides, NOS 
species (such as NO, ONOO-), disulfide bonds, metal ions and other elements can also intervene 
in the oxidation of CORM candidates through different mechanisms. 
Another possible pathway under mild conditions for CO release is decomposition of metal 
carbonyls complexes triggered by enzymes, which based on enzymatic reactions of intracellular 
enzymes with ligands of a specific tissue. The most famous known enzyme-triggered CORMs 
(ET-CORMs, Figure1.6 g) are η 4-acyloxy-cyclohexadiene-Fe(CO)3 complexes developed by 
Schmalz and his co-workers. [176] The unsaturated hydrocarbon Fe(CO)3 complexes were 
stimulated by an esterase that attacked the targeting ester group and produced a tautomeric dienol-
Fe(CO)3 complex intermediate. Then the temporary cleaved Fe-CO bond and finally led to the 
CO delivery process. Furthermore, a series of iron complex with a penicillin G amidase 
(PGA)‐cleavable unit was demonstrated that worked indeed in cell assays. [177] In conclusion, 
Studies concerning ET-CORMs present a new platform for providing selective controlled CO 
release in specific cellular environments.    
Diverse approaches can trigger carbon monoxide releasing molecules. Up to now, CORMs 
principally focus on the metal carbonyls complexes, therefore the choice of the metal ion is 
critically important. In theory, almost all transition metal CORMs with an appropriated ancillary 
ligand can be triggered. However, the metals of group 3, 4 and 5 generally form M-CO bond only 





unsaturated leaving unstable status as well as the necessary abandon of artificial and radioactive 
complexes. The complexes of Cr, Mn, Fe, Mo, Ru, W and Re from group 6, 7 and 8 are the most 
potential agents for CORMs, especially the complexes with kinetically stable 18 electrons. [169,178–
184] In addition, models of CORMs must consider the toxicity of metal residues to tissues and their 
metabolic pathway after decomposition. 
1.2.4. Photolytic release of CO from metal carbonyl complexes 
Photo-CORMs or photoactivated CORMs, as their name implies, are complexes that use light as 
an external trigger to achieve precise spatial and temporal control over CO releasing. Such photo-
CORMs generally require different wavelengths of incident light due to the nature of compound 
and the strength of the M-CO bond (for metal carbonyls) or R-CO bond (for pure organic 
carbonyls).  
As previously mentioned, CORM-1 and Fe(CO)5 are first reported photo-CORMs which need 
exposure to cold light while in some degree are not amenable to modification. [171] Therefore, 
studies on the photo induced metal carbonyls have been further developed, particularly on the 
sides of control light sensitivity and water solubility. Then Schatzschneider and co-workers 
established systematically the behavior study of [Mn(CO)3(tpm)]PF6 (CORM-L1, figure1.7 a) 
with and without irradiation. [185,186] This tris(pyrazolyl)methane (tpm) manganese tricarbonyl 
complex liberated CO upon irradiation with UV light in aqueous buffer, subsequently bringing 
about two of three CO ligands separation. Its bioavailability experiments on HT29 human colon 
cancer cells demonstrated that CORM-L1 reduced efficiently the viability of cancer cells and the 
flexibility of the tpm ligand architecture facilitated the preparation of water-soluble bioconjugates. 
In 2010, Ford and his co-works raised the term “photoCORM” and presented an air-stable, water-
soluble photoactivated tungsten carbonyl complex containing the trianionic 
tris(sulphonatophenyl)phosphine ligand (Figure 1.7 b). This moiety Na3W0(CO)5(TPPTS) 
released approximately one CO under irradiation, and the excess generated CO was produced 
through the oxidative process of a slow thermal reaction. [180] The group of Schatzschneider 





(bpy) or bpy related ligands that can conjugate to a peptide nucleic acid (PNA). [187] These metal-
PNA bioconjugates help to apply in the bio-sensing and biomedical applications.  
The first published photo-CORM activated by visible light is complex cis, trans, cis-dicarbonyl 
bis(2-thiolato-κS-ethylamin-κN) iron (II) (CORM-S1, figure1.7 c) reported by Westerhausen and 
his co-workers in 2011. [188] CORM-S1 exhibited light-induced CO release upon irradiation with 
LEDs at 470 nm in aqueous solution and was also indirectly proved by the measurement of 
activity of voltage- and Ca2+-activated potassium channels in excised membrane patches. Ford 
used a rhenium(I) luminescent molecule fac-[Re(bpy)(CO)3(thp)](CF3SO3) (bpy = 2,2′-bipyridine, 
thp = tris(hydroxymethyl)phosphine, figure1.7 d) to track the transformation of this photo-CORM 
before to its photolysis product in aerated aqueous solution. [189] This moiety with a band at 515 
nm released CO with a quantum yield of 0.11 when irradiated at 405 nm, accompanying with 
strong luminescence shift of photoproduct that exhibited a band at 585 nm, therefore can be used 
as an indicator to demonstrate the location where CO was released in cells. Through providing 
proper low-lying orbitals of ligands or increasing the extent of π back-bonding in the metal–CO 
bonds, Mascharak and his colleagues built [Mn(L)(CO)3]+ (L = ligands) systems with nitrogen-
containing bidentate or tridentate ligands and auxiliary ligands to increase the ability of CO 
liberation. Among these complexes, fac-[MnBr(azpy)(CO)3] (azpy = 2-phenylazopyridine) 
finished CO dissociation upon exposure to broadband light (λ  ≥ 520 nm) in the mixture media of 
H2O and ACN. [190] Furthermore, the group of Ford enhanced the CO uncaging by doping water-
soluble upconversion nanoparticles (UCNP) in a phospholipid-functionalized poly(ethylene 
glycol) layer (PEG layer) of lanthanide ions. [191] This system allowed the photochemical process 
to be activated by irradiation with infra-red light (NIR light) at 980nm and contributed to the 
photodynamic therapy. Coincidentally, Askes et al. recently reported an approach making use of 
mixing CORM-1 with a triplet-state photosensitizer to complete the CO delivery triggered by a 
red light at 635 nm. [4] Compared to the modification based on upconversion, this strategy utilized 






Figure 1.7 Selection of metal-based photo-CORMs. 
In summary, the potential of photo-CORMs to act as an exogenous therapeutic candidate has so 
far been well established. In this field, early studies mainly focused on the feasibility test of 
photo-CORMs and developed in ultraviolet-initiated complexes. Up to now, the growth of photo-
CORMs stimulated by visible and NIR light seems reasonably considerable and the interest in this 
aspect is still continuously increasing. 
1.3. General overview of NO and CO releasing materials 
1.3.1. NO and CO releasing molecules conjugates materials 
To achieve the biocompatible drug transfer in tissues, NO and CO releasing molecules are 
commonly incorporated with or encapsulated in variety of materials, which are called nitric oxide 
and carbon monoxide releasing materials (NORMAs and CORMAs). The NORMAs and 
CORMAs are therapeutic extensions of controlled NO and CO delivering devices. Diverse 
strategies are contributed to the gas storage in solid status as well as the specific trigger for the 
molecule liberation in organisms, such as the macromolecular conjugates, nanostructured 
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that the QDs were effective sensitizers to photochemical reactions to enable energy transfer with 
high efficiency. [126]  
Conjugation with biocompatible macromolecules is an attractive strategy to photo-NORMs and -
CORMs for developing in therapeutic applications. For example, NO-releasing dendrimers 
macromolecules prepared from functional primary and secondary amines can increase the storage 
capacity for gas molecule through the dendritic effect, which has been proved by kinetic studies 
of Schoenfisch. [198] The group of Schatzschneider covalently connected photo-CORM, 
[Mn(CO)3(tpm)]+ (tpm = tris(pyrazolyl)methane), to functionalized amino acids and model 
peptides (part of the tumor suppressor protein) via Sonogashira cross-coupling and via1,3-dipolar 
cycloaddition. [184] This peptides-derivative facilitated CO dissociation under microwave 
irradiation not through altering the photolysis properties of manganese moiety but through 
accelerating the reaction time and reducing the amounts of by-products. 
Metal–organic frameworks (MOFs, porous coordination polymers) are favorable solid-storage 
material for gaseous molecules owing to the high inner surface areas and ordered various-size 
pore channels with breathing effect. The so-called breathing effect in fact, is the reversible 
swelling of flexible MOF pores due to the solvent adsorption. Metzler-Nolte and coworkers 
prepared iron-based MOFs by a rapid microwave-assisted solvothermal method from iron(III) 
chloride and terephthalic acid and its derivatives. [199] These materials controlled the CO releasing 
rate by binding CO to accessible unsaturated coordination sites (CUS) in the frameworks. What is 
more, varying the MOF crystal size or morphology also helps to achieve the “gate-opening 
/closing” of CO delivery.  
1.3.2. Encapsulated NO and CO releasing materials  
Unlike approaches mentioned above, the group of Schiller non-covalently embedded the 
photosensitive metal carbonyls into polymer matrices via the electrospinning technique or 
miniemulsion. [192,200] The NORMAs or COMAs release NO or CO effectively into surrounding 
medium upon exposure to light and remain the toxic metal metabolites in the scaffold. It is 
noteworthy that the polymer is introduced a porous structure morphology to propel CO liberation 





accessible to aqueous environment and biological tissues by encapsulation in water-soluble and 
biocompatible polymer frames.  
Furthermore, Meinel and colleagues developed an oral carbon monoxide release system (OCORS) 
to deliver CORM tablets based on CORM-2 for the treatment of gastrointestinal diseases. [201] 
CORM-2 blending in a citric acid buffer and coated sodium sulfite crystals were encapsulated 
into the shell consisted of a semi-permeable membrane of cellulose acetate coating and PEG. The 
water medium diffused through the membrane and caused swelling of the coating layer around 
the Na2SO3 crystals leading to rapid dissolution. Thus, dissolved sulfite salts initiated CO-release 
through ligand substitution. The membrane thickness ensures CORM stability during storage and 
to some extent limits the CO release. The OCORS system is functional independent of 
environment in biology, providing precise control over sustained CO delivery. 
1.4. Scope of the thesis 
The present thesis focuses on the light-responsive nitric oxide releasing molecules (NORMs) and 
carbon monoxide releasing molecules (CORMs) based on transition metal ruthenium (Ru) and 
manganese (Mn) complexes. A general introduction and brief development of NORMs and 
CORMs are given in the first chapter. Chapter 2 describes series of photolabile {RuNO}6 
nitrosyls containing carboxamido-N and pyridine donors which fluorine substitution at different 
positions within the molecules thereof. In this section, the synthesis and characterization of metal 
nitrosyls are introduced as well as the influence of fluoro-substitution on NO-releasing studies are 
also investigated. In addition, the photo behaviors and mechanism analysis of the fluorinated 
ruthenium carbonyl complexes with same ligands as {RuNO}6 nitrosyls are represented in chapter 
3. Next, the Chapter 4–6 demonstrate water soluble photo-CORMs based on manganese(I) 
tricarbonyls center which conjugated to a fluorobenzene group, dabsyl chromophoric ligand and 
nitrobenzodiazole fluorophore group, respectively. A fluorinated manganese-based photo-CORM 
in chapter 4 combines with 19F spectroscopy, aiming to provide a new strategy for tracking the 
photolysis of donor molecules through the NMR spectral change. Furthermore, the photo-CORMs 
presented in chapter 5 and 6 release CO under irradiation with visible light, simultaneously 
achieving the colorimetric and/or fluorometric response. 




2. Fluorinated ruthenium NO releasing molecules  
This chapter describes series of light-triggered fluorinated ruthenium nitrosyl complexes with a 
carboxamide-bis-pyridyl group. Fluorine ion was used to substitute different pyridyl-H within the 
ligand molecules and the formed ligands further reacted with ruthenium precursor to obtain the 
six-coordinate photo-NORMs Ru(X-Fbpb)(NO)Cl. These fluorinated ruthenium nitrosyls were 
highly stable under solution conditions and aerobic environment. Upon exposure to low intensity 
UV light at 405 nm, all photo-NORMs achieved NO release with ruthenium oxidation state 
changes from +2 to +3. The photochemical reactions were detected via fluorescence assay with 
the presence of NO550 probe.  
2.1. Introduction 
2.1.1. Ruthenium nitrosyls for NO release 
As previously mentioned, light-induced metal NO releasing molecules have attracted 
considerable interest. A variety of NORMs based iron, manganese and ruthenium are reported. 
Among these transition metal nitrosyls, ruthenium complexes have a great advantage on stability 
especially over long periods under physiological medium as well as the disadvantage of relatively 
low quantum yield for NO release and the requirement of UV light for photoactivation. [145] 
Alteration of the coordinated ligand frame was required to overcome this deficiency.  
The carboxamide-bis-pyridine based ligand was applied to synthesis {Ru-NO}6 photo-NORMs. 
The pyridyl ligands and the deprotonated amido ligands will activate the Ru-NO moiety toward 
photolysis of NO by increasing electron density onto the nitrosyl group due to the strong π-
donation. [202] Moreover, their propensity toward water solubility and biocompatibility render 
chelated complexes applicable to physiological situations where NO is needed as a drug agent. 
Consequently, the tetradentate ligands facilitate NO liberation and stabilize ruthenium complexes 
in high oxidation states that remain after photolysis. Thus, the photochemical reaction of NO can 
be achieved within a short time with low recombination rates. Within the octahedral structures, 




ligands trans bound to NO resulting in red shifts of absorption and N-O stretching frequency due 
to the increase in the in-plane ligand field strength. [111] 
2.1.2. Fluorescence assay for the determination NO release 
The most common approach for determination NO release is to form fluorescent triazole 
derivatives by using o-diamino aromatics, which can react with NO+ or N2O3 under aerobic 
conditions. [203,204] However, majority of these NO probes are generally affected by pH and 
interferent such as •OH and •NO2, leading to a limited detection environment. 5-amino-6-(3-
(dimethylamino)phenyl)-1-naphthonitrile (NO550) is a highly selective fluorescence indicator for 
NO detection. [205] This NO scavenger is developed by Anslyn and co-workers and can react with 
NO+ in solution to generate a fluorescent diazo ring compound 9-(dimethylamino) dibenzo [c,h] 
cinnoline-1-carbonitrile (AZO550) shown in Scheme 2.1.  
 
Scheme 2.1 Probe NO550 and its detection mechanism. [179] 
For the fluorescence assay, at least 20 % DMSO in PBS buffer is required to dissolve NO550 
because of its limited aqueous solubility. Once capturing NO, an emission band that centered at 
550 nm grew and fluorescence intensity increased until no free NO liberated. The fluorescence 
intensity was found linear correlated with NO concentration (R2 = 0.997) and the reaction kinetic 
was considered as multiexponential, allowing a superior for NO detection under both intra- and 
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broad absorption band in the range of 600-900 nm were shown in Figure 2.2 a. With illumination 
time increasing, the absorption bands grew gradually and increased with an isosbestic point at 395 
nm. Simultaneously occurred the color change of the solution from light yellow to dark. When 
solutions of the complexes Ru(3-Fbpb)(NO)Cl (5) and Ru(5-Fbpb)(NO)Cl (6)  in DMSO/ACN 
(1:9) are exposed to UV light under same conditions, similar spectral changes have been observed. 
The resulting optical spectral changes are consistent with substitution of bound NO by ACN 
(solvent) molecules.  
 
The NO dissociation rates (kNO) of 5-7 are 2.83 × 10-3 s-1, 2.62 × 10-3 s-1 and 3.57 × 10-3 s-1, 
respectively. Under our conditions (DMSO/ACN solution, 10mW/cm2, λexc = 405 nm, 7.5 cm 
distance from excitation lamp), Ru(bpb)(NO)Cl showed a reaction release rate of kNO = 3.09 × 10-
3 s-1. While Mascharak et al. determined a NO dissociation rate of kNO = 1.23 × 10-2 s-1 in ACN 
solution (7 mW/cm2, λexc = 302 nm, 3 cm distance from excitation lamp).  
A possible photo-release of NO and conversion to the solvato species is indicated by the 
formation of the bathochrome band around 440 nm. No back reaction is observed when the light 
is turned off, which means no NO recombination without irradiation. The photoproducts display a 
broad low-energy band in the range of 600–900 nm, which arises from F-bpb2- to Ru(III) charge 
transfer transition (ligand to metal charge transition, LMCT). Similar low-energy LMCT bands 
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Figure 2.3 Time evolution of liquid-phase IR spectra during irradiation of Ru(6-Fbpb)(NO)Cl (7) solution 
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In brief, these results confirm that the ruthenium complexes can be triggered by UV light with 
low intensity to release coordinated NO in solution. The photochemical reactions of NORMs start 
from the admixture of dπ orbitals that consisted of d orbitals of ruthenium center and antibonding 
π orbitals of nitrosyl ligands. 




2.3. Summary and Conclusion 
In conclusion, a series of ruthenium complexes with fluorinated carboxamide ligands that release 
NO upon low intensity irradiation are introduced in this chapter. DFT and TD-DFT calculations 
are given to describe the conjugation of ruthenium nitrosyls and investigate the NO release 
mechanism. It is clearly confirmed that the photochemical reactions originate from the admixture 
of dπ orbitals that consisted of d orbitals of ruthenium center and antibonding π orbitals of nitrosyl. 
Furthermore, the substitution of fluorine at the ortho position of the aromatic ring conducted as 
withdrawing functional group influenced electron density of the π-electrons and reduced the 
stacking interaction. This leads to a longer bond length of Ru-NO in Ru(6-Fbpb)(NO)Cl 
compared to bond length in Ru(bpb)(NO)Cl, facilitating photolysis of NO.   
 




2.4. Experimental section 
2.4.1. General procedure 
Materials and instrumentation.  
1,2-diaminobenzene, triphenyl phosphite, NaH, RuCl3·3H2O and fluoropyridine-carboxylic acid 
were purchased from commercial sources. All solvents were purified and dried by standard 
techniques prior to use during syntheses to avoid exposure to dioxygen and moisture. 1H NMR, 
13C NMR and 19F NMR spectra were recorded AV 400 MHz Bruker NMR spectrometer using 
CDCl3 and DMSO-d6 as the solvents. Tetramethylsilane (TMS) as an internal standard for 1H 
NMR, whereas trichlorofluoromethane (CCl3F) as an internal standard for 19F NMR. All IR (ATR) 
spectra were recorded on a Bruker Vertex 70 FT-IR spectrometer. UV-Vis spectra were recorded 
on an Analytik Jena Specord S 600 UV-Vis spectrometer and absorption spectra were recorded on 
a Cary 50 Varian spectrophotometer. Fluorescence spectra were recorded on a Perkin Elmer 
LS50B luminescence spectrometer. Mass spectra were obtained by the use of a Finnigan MAT 
SSQ 710 or MAZ95XL device. Elemental analysis was performed on a Vario EL III CHNS 
instrument.  
General experimental methods for UV-Vis and fluorescence studies.  
1 mM stock solution of NORMs was prepared in nitrogen-bubbled DMSO, which was used for 
all the studies. Unless not otherwise mentioned, the DMSO stock solutions were diluted with 
phosphate buffer (PB, pH 7.4) or ACN solution, and the effective final concentration was made as 
0.1 mM. Thus, the diluted solution was used for all spectroscopic studies. All luminescence 
measurements were done using λex = 470 nm with an emission slit width of 3 nm. Each spectrum 
was recorded at room temperature with a quartz cuvette at regular time intervals of UV light 
exposure (UVP Benchtop 2 UV Transilluminator, ≤ 10 mW/cm2) at different wavelengths (365 
nm and 405 nm). 
Photolysis Experiment.  
For UV-Vis spectroscopic measurements, the DSMO stock solution was further diluted with 




phosphate buffer (PB:DMSO, 9:1, v/v, pH 7.4) and acetonitrile (ACN:DMSO, 9:1, v/v), Solution 
of NORMs (0.1 mM) in a quartz cuvette were exposed to different light sources (365 nm and 405 
nm, 10 mWcm−2) with an interval of every 10 min over a period of 2 h to confirm the 
photoactivities of ruthenium nitrosyls. The power of the light sources was determined with a 
PM100USB power meter. Absorbance values at specific wavelength were obtained from the 
respective spectra, and the observed rate constant kNO was calculated from the equation:  
At = A∞ + (A0 − A∞){exp(-𝑘NO × 𝑡 )}                      (𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 2.1) 
where At is the absorbance at time t after irradiation, A0 and A∞ are the initial and final 
absorbances. [207,211] The reaction rate constant values kNO is obtained by fitting the absorbance 
values to the equation versus irradiation time. 
The fluorescence assay was performed in an oxygen-free mixture of DMSO and phosphate buffer 
(PB:DMSO, 8:2, v/v). 3 mL solution containing excess NO550 (50 µM) and Ru-NO complex (16 
µM) was recorded upon irradiation at every 5 min intervals for 90 min to investigate the photo-
triggered NO release studies. 
2.4.2. Synthesis and measurements 
Synthesis of N, N'-(1,2-phenylene)bis(X-fluoropicolinamide), ligands.  
The ligands (1-4) were prepared according to the modified method by Vagg et al. [186,209] A 
solution of fluoropyridine-carboxylic acid (6 mM, 0.8466 g) in pyridine (2.4 mL) was added to a 
pyridine solution (0.6 mL) that contained 1,2-diaminobenzene (3 mM, 0.324 g). After the addition 
of triphenyl phosphite, the mixture was stirred at 80 ºC  overnight. The reaction mixture was 
filtered and the residue was washed with dry diethyl ether several times to yield a corresponding 
white solid ligand. 
N,N'-(1,2-phenylene)bis(3-fluoropicolinamide), 3-Fbpb (1): 
1H NMR (400 MHz, CDCl3), δ (ppm):10.26 (s, 2 H), 8.23 (d, J = 8.24 Hz, 2H), 8.09 (dd, J = 7.80 
Hz, 2 H), 7.76 (dd, J = 7.60 Hz, 2H), 7.44 (dd, J = 6.05 Hz, 2 H), 7.36 (dd, J = 6.05 Hz, 2H). 13C 
NMR (150 MHz, CDCl3), δ (ppm): 149, 148, 137, 130, 126, 126, 124, 122. 19F NMR (400 MHz, 




CDCl3), δ (ppm): -122. IR (ATR): ν = 1637, 1602, 747, 615, 502 cm-1. ESI-MS (m/z) 
C18H12N4F2O2, calculated for: 354.31, observed: 354. 
N,N'-(1,2-phenylene)bis(4-fluoropicolinamide), 4-Fbpb (2):  
1H NMR (400 MHz, CDCl3), δ (ppm):10.39 (s, 2 H), 8.23 (d, J = 8.24Hz, 2 H), 8.09 (dd, J = 7.80 
Hz, 2 H), 7.76 (dd, J = 7.60 Hz, 2 H), 7.44 (dd, J = 6.05 Hz, 2 H), 7.36 (dd, J = 6.05 Hz, 2 H). 13C 
NMR (150 MHz, CDCl3), δ (ppm): 149, 148, 135, 132, 127, 126, 124, 122. 19F NMR (400 MHz, 
CDCl3,) δ (ppm): −100. IR(ATR): ν = 1653, 1601, 743, 653, 581 cm-1. ESI-MS (m/z) 
C18H12N4F2O2, calculated for: 354.31, observed: 354. 
N,N'-(1,2-phenylene)bis(5-fluoropicolinamide), 5-Fbpb (3):  
1H NMR (400 MHz, CDCl3), δ (ppm): 10.05 (s, 2 H), 8.23 (d, J = 8.24 Hz, 2 H), 8.09 (dd, J = 
7.80 Hz, 2 H), 7.76 (dd, J = 7.60 Hz, 2 H), 7.44 (dd, J = 6.05 Hz, 2 H), 7.36 (dd, J = 6.05 Hz, 2 
H). 13C NMR (150 MHz, CDCl3), δ (ppm): 149, 148, 137, 130, 126, 125, 124, 122. 19F NMR (400 
MHz, CDCl3,) δ (ppm): -121. IR (ATR): ν = 1637, 1598, 734, 623, 577 cm-1. ESI-MS (m/z) 
C18H12N4F2O2, calculated for: 354.31, observed: 354. 
N,N'-(1,2-phenylene)bis(6-fluoropicolinamide), 6-Fbpb (4):  
1H NMR (400 MHz, CDCl3), δ (ppm):10.39 (s, 2 H), 8.23 (d, J = 8.24, 8.22, 0.95 Hz, 2 H), 8.09 
(dd, J = 7.80, 1.05 Hz, 2 H), 7.76 (dd, J = 7.60, 4.76, 1.15 Hz, 2 H), 7.44 (dd, J = 6.05, 3.49 Hz, 2 
H), 7.36 (dd, J = 6.05, 3.49 Hz, 2 H). 13C NMR (150 MHz, CDCl3), δ (ppm): 149, 148, 137, 130, 
126, 125, 124, 122. 19F NMR (400 MHz, CDCl3,) δ (ppm): -68.19. IR (ATR): ν= 1637, 1601, 757, 
633, 521 cm-1. ESI-MS (m/z) C18H12N4F2O2, calculated for: 354.31, observed: 354. 
Synthesis of Trichloronitrosylruthenium, Ru(NO)Cl3(H2O)2.  
Ru(NO)Cl3(H2O)2 was synthesized according to a published method. [131,202] Ruthenium(III) 
chloride hydrate (RuCl3(H2O)3, 2.00 g, 0.0096 mol) was dissolved in 18 ml diluent hydrochloric 
acid (HCl, 1 M) and heated to 100 ºC. 5 mL aqueous solution of sodium nitrite (NaNO2, 1.99 g, 
0.0288 mol) was added dropwise over a period of one hour to form a dark red solution. After 1 h, 
the solvent was removed from the purple reaction mixture under vacuum with rotary evaporator at 
90 ºC. Then the remaining dark purple oil was dissolved in ethanol. The NaCl precipitate formed 
in the reaction was separated from product via vacuum ﬁltration. Ethanol was removed in vacuum 




with a rotary evaporator. The extremely hygroscopic purple residue was dried and stored in a 
desiccator. 
IR (ATR): ν = 1884 cm-1.  
Synthesis of NORMs, Ru(X-Fbpb)(NO)Cl.  
A slurry of NaH (0.015 g, 0.625 mM) in 2 mL DMF was added to a stirred solution of Ligand 
(0.1198 g, 0.314 mM) in 3 mL of dry DMF. The color of the solution turned clear yellow when 
the evolution of hydrogen gas stopped. A solution of Ru(NO)Cl3(H2O)2 (0.082 g, 0.314 mM) in 4 
mL dry DMF was added to the reaction mixture. The color of the solution turned dark brown 
immediately. The solution was refluxed under nitrogen atmosphere for 20 h. The dark brown 
solution was cooled to room temperature and filtered to remove NaCl. Then the mixture was 
concentrated to 2 mL. Diffusion of Et2O into this solution yielded a dark brown solid (72%). 
Ru(3-Fbpb)(NO)Cl (5):   
1H NMR (400 MHz, DMSO-d6), δ (ppm): 8.95 (1H, d, J = 8.0 Hz, ArH); 8.57 (2H, d, J = 5.6 Hz, 
ArH); 8.26 (1H, t, J = 8.8 Hz, ArH); 8.15 (1H, d, J = 7.6 Hz, ArH); 7.43- 7.21 (3H, m, ArH). 13C-
NMR (125 MHz, DMSO-d6): δ (ppm) 164, 157, 145, 144, 128, 126, 123, 122. 19F NMR (400 
MHz, DMSO-d6), δ (ppm): -148. IR(ATR): ν =1846cm−1 (νNO, s), 1935 cm−1 and 1586 cm−1 (νCO 
stretchings). ESI-MS (m/z) C18H10F2N4O3ClRu, calculated for: 519, observed: 508. Elemental 
analysis C18H10F2N4O3ClRu, calculated: C = 41.67%, H = 1.94%, F = 7.32%, Ru = 19.48%, N = 
13.50%, O = 9.25%, found: C = 43.44%, H = 2.11%, N = 13.17%   
Ru(5-Fbpb)(NO)Cl (6):   
1H NMR (400 MHz, DMSO-d6), δ (ppm): 8.95 (1H, d, J = 8.0 Hz, ArH); 8.57 (2H, d, J = 5.6 Hz, 
ArH); 8.26 (1H, t, J = 8.8 Hz, ArH); 8.15 (1H, d, J = 7.6 Hz, ArH); 7.41- 7.21 (3H, m, ArH). 13C-
NMR (125 MHz, DMSO-d6): δ (ppm) 163, 157, 145, 143, 128, 125, 113, 122. 19F NMR (400 
MHz, DMSO-d6), δ (ppm): -119.  IR(ATR): ν =1861 cm−1 (νNO, s), 1645 cm−1 (νCO stretchings). 
ESI-MS (m/z) C18H10F2N4O3ClRu, calculated for: 519, observed: 478. Elemental analysis 
C18H10F2N4O3ClRu, calculated: C = 41.67%, H = 1.94%, F = 7.32%, Ru = 19.48%, N = 13.50%, 
O = 9.25%, found: C = 42.73%, H = 2.51%, N = 12.87%  




Ru(6-Fbpb)(NO)Cl (7):   
1H NMR (400 MHz, DMSO-d6), δ (ppm): 8.95 (1H, d, J = 8.0 Hz, ArH); 8.57 (2H, d, J = 5.6 Hz, 
ArH); 8.26 (1H, t, J = 8.8 Hz, ArH); 8.15 (1H, d, J = 7.6 Hz, ArH); 7.24- 7.41 (3H, m, ArH). 13C-
NMR (125 MHz, DMSO-d6): δ (ppm) 164, 158, 147, 141, 127, 126, 121, 120. 19F NMR (400 
MHz, DMSO-d6), δ (ppm): -60. IR(ATR): ν =1852 cm−1 (νNO, s), 1956 cm−1 and 1633 cm−1 (νCO 
stretchings). ESI-MS (m/z) C18H10F2N4O3ClRu, calculated for: 519, observed: 541[Na+]. 
Elemental analysis C18H10F2N4O3ClRu, calculated: C = 41.67%, H = 1.94%, F = 7.32%, Ru = 
19.48%, N = 13.50%, O = 9.25%, found: C = 41.99%, H = 1.89%, N = 13.82%. 




3. Fluorinated ruthenium CO releasing molecules  
This section focuses on a collection of ruthenium-based CO releasing molecules with identical 
ligands system of ruthenium nitrosyl complexes described in chapter 2. This series products 
originate from a compound Ru(bpb)(CO)(H2O), which is a complex published by group 
Viswanathamurthi and group Akermark and worked as an efficient catalyst. [212,213] The photolysis 
of this compound has been evaluated by Dr. Bohlender in our group and the results showed that 
Ru(bpb)(CO)(H2O) cannot be triggered by light to release CO. Inspired Ru(X-bpb)(NO)(Cl) 
complexes, substitution with fluorine was applied for facilitating the CO dissociation. These 
ruthenium carbonyls are stable under physiological conditions, except Ru(5-Fbpb)(CO)(H2O) is 
degradable in solution environment. In addition, Ru(6-bpb)(CO)(H2O) can release CO upon 
illumination with light at 405 nm. It is clearly confirmed this modification successfully improved 
the photoactivity.     
3.1.   Introduction 
3.1.1. Ruthenium carbonyls for CO release 
Transition metal ruthenium lies in the second row with a large d-orbital splitting leading to 
ruthenium carbonyls are commonly considered as having a low spin Ru(II)-CO0 electron 
configuration. This also contributes to more air-stable and less labile of light-responsive 
ruthenium carbonyl complexes compared to other metal carbonyl complexes. Ruthenium pyridyl 
complexes are widely employed in biomedical and biophysical field for their well-known 
photophysical and photochemical properties. Ruthenium (II) bipyridyl complexes were found not 
accumulate in the nucleus and were transferred by endocytosis or by active transport. Cheng et al. 
represented that outer membrane protein (OmpF) involved in the transportation of polypyridyl 
ruthenium complexes into Escherichia coli. [214] This provided a solution to metal metabolites 
after photodegradation. Thereby, ruthenium based pyridyl derivatives were introduced as potential 
CO donors to biological targets. Strategies to improve the sensitivity to visible light gained an 




increasing interest.  
3.1.2. Myoglobin assay for the determination CO release 
To quantify the amount and rate of CO liberated from CORMs, real-time and reliable methods are 
required. Myoglobin assay is a very common technique to monitor CO release from metal 
carbonyl complexes based on spectral changes in absorption, which was first introduced by 
Motterlini and co-workers in 2002. [171,215,216] This method uses haem containing protein 
myoglobin (Mb) as a CO scavenger. Horse heart myoglobin is commonly used in this assay 
because its protein impurities can be eliminated as a source of isosbestic point loss/ translation at 
enough low concentrations. Firstly, sodium dithionite was added to convert commercially 
myoglobin source (metmyoglobin, Fe3+) to deoxymyoglobin (deoxy-Mb, F2+). The formed deoxy-
Mb can react rapidly with free CO to generate carboxymyoglobin (CO-Mb) with a rate constant 
of k = 0.38 μM/s (binding constant = 16.9 μM/s). This reaction of deoxy-Mb with CO can be 
followed by UV-Vis spectroscopy through observing the spectral change in the Q-bands of heme 
group. The absorption band of deoxy-Mb at 557 nm decreases and divides into two new 
absorption bans of CO-Mb respectively at 540 nm and 577 nm. This assay is generally performed 
at simulant physiological conditions (pH= 74, 37 °C). In addition, a small excess of reducing 
agent (sodium dithionite) is needed to eliminate the influence of incoming oxygen which also can 
bound with deoxy-Mb rapidly and prevent release CO upon oxidation. It is noted that accurate 
starting concentration of myoglobin can be corrected with reference extinction coefficients of ε540 
= 15.40 mM-1cm -1 and ε560 = 13.80 mM-1cm -1. The resulting proportion of CO-Mb converted 
from deoxy-Mb can be evaluated by determination the absorption band at 540 nm.  





















Figure 3.1 Q-bands region of absorption spectra for deoxymyoglobin and carboxymyoglobin in phosphate 
buffer (pH = 7.4). 
However, the concentration of CO-Mb formed over time cannot be applied to calculate a reliable 
rate constant due to the possible multiple CO ligands in CORMs. [216] When a CORM complex 
contains more than one CO ligands in the molecule, the fragments result from photoreaction after 
its first CO release might accelerate or decelerate further CO liberation. Therefore, a concept of 
half-life (t1/2) is commonly used to quantitatively determinate CO releasing. It is described as the 
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161.4−164.3 ppm and 157.8−159.1 ppm of Ru(6-Fbpb)(CO)(H2O) are assigned to the carbonyl 
carbon (C=O) and the pyridyl carbon. [213] Peaks around 31.2−39.6 ppm correspond to benzene 
carbon. Additionally, a peak at 201.6 ppm is due to the C≡O carbon resonance. The respective 19F 
NMR spectra of ruthenium nitrosyls were recorded to further confirm the involvement of the 
pyridine group. Certain chemical shifts were observed (Δδ = 8 ppm for Ru(6-Fbpb)(CO)(H2O)). 
In addition to the corresponding IR spectra, this result confirms the metal coordination and 
introduction of CO through the appearance of the stretching frequency νC≡O at 1923 cm-1 and the 
disappearance of the NH band at around 3313 cm-1. The band at 1539−1669 cm-1 are assigned to 
carbonyl amide I (νC=O) stretching frequency upon complex formation. The corresponding amide 
II (νC-N) at 1468 cm-1 and amide III (δN-H) at 1262 cm-1 result from the deprotonation of amide 
functionality. Further the band of pyridine ring deformation at 600-630 cm-1 in the ligands shifts 
to a higher frequency at 640-660 cm-1 in ruthenium complexes. Similar changes can be observed 
in the other ruthenium carbonyl complexes.   
DFT calculations were performed to analyze the structure of ruthenium carbonyl complexes. 
Calculated and experimental data agree well for Ru(bpb)(CO)(H2O). [213] DFT predicts a nearly 
linear CO coordination with a (Ru-C-O) angle of 175.8 °. The tetradentate ligands (F-bpb) in its 
deprotonated form provides two neutral pyridine N and two anionic carboxamido N donors in the 
nearly plane of the neutral complex; the axial positions are occupied by carbonyl and water ligand. 
The geometry around the Ru(II) center is axially distorted octahedral. The planes of pyridyl and 
benzene rings slightly deviate from each other and tilt away from the tertiary pyridyl plane. 
Coordination bonds of the ruthenium center to the negative charged carboxamide group (Ru-
Namide) are about 0.1 Å shorter compared to the interaction within the Ru-Npy bonds. The axial 
carbon monoxide is almost linearly bound to the ruthenium center with a distance of 1.795 Å and 
the length of the C≡O bond is 1.173 Å. The long bond length of Ru-Owater (2.163 Å) is assigned to 
the weak σ-bond and lack of π-bonding between the ruthenium and water ligand. Moreover, the 
distance of Ru-CCO (1.795 Å) results from the σ-donor and of π-acceptor carbonyl ligand.  
Table 3.2: Calculated bond lengths (Å) and angles (°) for the ruthenium carbonyl complexes. Experimental 
values are given in parentheses. As Ru(6-Fbpb)(CO)(H2O) exhibits only C1 symmetry the two (Ru-N) 
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Figure 3.2 Absorbance spectrum of Ruthenium carbonyls in DMSO/H2O (20:80, v/v) solution (0.1 mM) 
upon irradiation with 405 nm at 10 mW cm-2 in 10 mins intervals for 120 min. (a) Ru(bpb)(CO)(H2O), (b) 
Ru(3-Fbpb)(CO)(H2O), (c) Ru(5-Fbpb)(CO)(H2O) inset: absorbance at 315 nm as a function of irradiation 
time, (d) Ru(6-Fbpb)(CO)(H2O). 
For Ru(bpb)(CO)(H2O), two main absorption bands at 308 nm and 415 nm respectively were 
observed in the Figure 3.2 a. The former is explained by a metal to ligand charge transfer (MLCT) 
from dRu to π*CO. This absorption band decreased gradually and presented a slight redshift upon 
illumination. The absorption band at 415 nm changed to blurred and smooth because the 
absorption minimum at 385 nm increased and a broad absorption at 436−600 nm grew. 
Additionally, two isosbestic points were formed at 279 nm and 339 nm.  
There were also two main absorption bands of Ru(3-Fbpb)(CO)(H2O) at 298 nm and 415 nm, 
which was shown in Figure 3.2 b. Both absorption bands decreased with irradiation time 
increasing and no isosbestic point was observed, indicating the stability on the compound in 
solution. Figure 3.2 c is the evolution of absorption spectra for Ru(5-Fbpb)(CO)(H2O) under 
illumination with light at 405 nm within 15 min. Two strong absorption bands at 315 nm and 408 
nm represented a dramatical decline; ultimately the latter almost completely disappeared. 
Moreover, an alike tendency was found upon exposure to light at 365 nm, indicating a violent 
reaction of the compound. However, IR spectra of Ru(5-Fbpb)(CO)(H2O) in solvent 
environments (Figure 3.3) demonstrated that the spectral variation cannot attribute to the CO 
release but the degradation in solution. Once completely dissolved in solvents, IR spectra of 
compound solution was immediately performed. The characteristic stretching frequency νC≡O at 
around 1923 cm-1 disappeared, confirming the instability of Ru(5-Fbpb)(CO)(H2O) in such 
solutions. For Ru(6-Fbpb)(CO)(H2O), there were three main absorption bands at 306 nm, 357 nm 
and 415 nm respectively observed from Figure 3.2 d. With illumination time increasing, all three 
absorption bands decreased gradually and a new broad absorption band at 490−600 nm grew and 
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theory. [141,217,218] All investigated complexes exhibit similar frontier orbitals. The metal ions are 
Ru(II) in the low-spin state with a closed-shell electron configuration ground state for the 
ruthenium carbonyls. The HOMO-1 and HOMO are πL-orbitals located on the carboxamide 
moiety of the co-ligands. The former HOMO-1 orbitals are consisted of dπ orbitals of the metal 
and are non-bonding towards CO. While HOMO orbitals bound with respect to CO ligand with a 
constitution of amide and phenylene orbitals and lie energetically about 2.1 eV below the HOMO 
in all complexes. They are responsible for the π-back donation interaction between the ruthenium 
and the carbon monoxide. Furthermore, the LUMO and LUMO+1 orbitals corresponding to 
antibonding dπ*-orbitals are mainly contributed by dπ*pyridine -orbitals, dπ-Ru orbitals and CO 
character. Similar to Ru(6-Fbpb)(NO)Cl described in chapter 2, ruthenium carbonyl substituted 
with fluorine at ortho position holds a longer Ru-CO bond length compared to the other 
ruthenium complexes, facilitating the release of CO from the metal. Upon illumination, the 
photoreaction of Ru(6-Fbpb)(CO)(H2O) originates from the admixture of dπ → π*ligand MLCT 
character, subsequently πRu-CO bond is weakened to release the CO from the metal remaining 
corresponding solvent molecule for originally bounded carbonyl.  
In brief, these results confirm that the Ru(6-Fbpb)(CO)(H2O) can be triggered by UV and visible 
light with low intensity to release one equivalent coordinated CO. The photochemical reaction of 
this ruthenium carbonyl starts from the admixture of dπ orbitals that consisted of d orbitals of 
ruthenium center and antibonding π orbitals of carbonyls. 
3.2.4. Quantitative 19F NMR analysis for Ru(6-Fbpb)(CO)(H2O) upon irradiation 
Time-dependent 19F NMR spectroscopy was used to monitor the photodegradation of Ru(6-
Fbpb)(CO)(H2O). 4 mg photo-CORM was dissolved in 6 mL nitrogen-bubbled DMF and DMSO 
solution respectively. There is one initial signal peak at −60.97 ppm of the compound in DMF 
solution (Figure 3.4 b). Upon illumination, quite slightly chemical shifts toward high-field were 
observed, indicating that the chemical environment of CORM residue has changed.  Moreover, 
19F NMR spectra demonstrated that a new peak at −61.10 ppm grew after 30 min irradiation and 
increased gradually. Interestingly, no obvious change was found in DMSO solution that is shown 
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3.3. Summary and conclusion 
In summary, a collection of ruthenium-based CO releasing molecules with fluorinated 
carboxamide ligands are synthesized. Substitution with fluorine influence the photoactivity of 
carbonyl complexes. Among them, Ru(6-bpb)(CO)(H2O) are highly stable under aerobic 
conditions as well as in solution environment. It releases CO upon illumination with low intensity 
light at 405 nm. DFT calculations confirm the photolysis of CO of Ru(6-bpb)(CO)(H2O) starts 
from the admixture of d orbitals of metal center and antibonding π orbitals of ligands. 
Furthermore, quantitative 19F NMR is well established to discrimination the photochemical 
reaction. In this work, a new peak grew and increased gradually in the time-dependent 19F NMR 
spectra. The amount of photo-product represented by integrals of peaks was basically same with 
the amount of released CO recorded from myoglobin assay, which confirmed the feasibility of 19F 
NMR spectroscopy to quantitatively analysis CO release from mono-carbonyl CORM. This 
strategy opens a new direction for detecting photo-CORMs containing fluorine.  
 




3.4. Experimental section 
3.4.1. General procedure 
Materials and instrumentation.  
1,2-diaminobenzene, triphenyl phosphite, triruthenium dodecacarbonyl (Ru3(CO)12) and 
fluoropyridine-carboxylic acid were purchased from commercial sources. All solvents were 
purified and dried by standard techniques prior to use during syntheses to avoid exposure to 
dioxygen and moisture. 1H NMR, 13C NMR and 19F NMR spectra were recorded AV 400 MHz 
Bruker NMR spectrometer at room temperature using CDCl3 and DMSO-d6 as the solvents. 
Tetramethylsilane (TMS) as an internal standard for 1H NMR, whereas trichlorofluoromethane 
(CCl3F) as an internal standard for 19F NMR. All IR (ATR) spectra were recorded on a Bruker 
Vertex 70 FT-IR spectrometer. UV-Vis spectra were recorded on an Analytik Jena Specord S 600 
UV-Vis spectrometer and absorption spectra were recorded on a Cary 50 Varian 
spectrophotometer. Mass spectra were obtained from a Finnigan MAT SSQ 710 or MAZ95XL 
device. Elemental analysis was performed on a Vario EL III CHNS instrument. Fluorescence 
spectra were recorded on a Perkin Elmer LS50B luminescence spectrometer. 
General experimental methods for UV-Vis study and myoglobin assay.  
0.1 mM stock solution of CORMs in DMSO/H2O (2:8) was used for all the studies. Photocycles 
with UV-A excitation light (λ = 366 nm) were performed on a Cary 5000 UV-Vis/NIR 
spectrometer, which equipped with a 250 W mercury lamp (10 mW/cm2). The cuvette was held at 
a fixed distance of 20 cm from the grid in the illumination apparatus. Absorption spectra were 
taken after each irradiation for a certain period of time at different wavelengths. 
Solution of ruthenium carbonyls (100 µM) in a quartz cuvette was exposed to UV light at 365 nm 
and 405 nm at every 10 min intervals to investigate the absorption spectrum.  
The light-induced CO release under illumination with a 405 nm LED arrays (10 mW/cm2) was 
also detected by a PAC7000 electrochemical CO Sensor (Drägerwerk AG & Co. KGaA, Lübeck, 
Germany) within an enclosed setup.  




CO release study.  
A solution of the corresponding complex in DMSO: PBS (20:80, v/v, volume V = 3.0 mL) was 
transferred to a stirred quartz cuvette (1 cm pathlength) at 20 °C in a UV-Vis absorption 
spectrometry setup. The volume of CORM solution and volume of myoglobin solution should be 
equal.   
CCO-Mb = (𝐴t540 – 𝐴0540) / [d × (𝜀 540− 𝜀0540)]                   (Equation 3.1) 
where 𝐴t540 is the absorbance at 540 nm at each timepoint t, 𝐴0540 is the initial absorbance at 540 
nm, d is pathlength of the cuvette (d = 1 cm) and ε540 (15.40 mM-1 cm-1) is the extinction 
coefficient at 540 nm according to literature. [216] 𝜀0 is corrected initial extinction coefficient in 
phosphate buffer and is obtained from the following equation: 
𝜀0540= (𝐴0540) / [d × (C0 deoxy-Mb/2)]                         (Equation 3.2) 
where C0 deoxy-Mb is calculated with starting absorbance at 560 nm Adeoxy-Mb560 and extinction 
coefficient 𝜀560 (13.80 mM-1 cm-1) at 560 nm. 
19F NMR analysis for Ru(6-Fbpb)(CO)(H2O) upon irradiation. 
19F NMR spectra of Ru(6-Fbpb)(CO)(H2O) were recorded AV 400 MHz Bruker NMR 
spectrometer at room temperature using DMSO-d6 as the solvents with trichlorofluoromethane 
(CCl3F) as an internal standard. 
Table 3.2 Characteristic peak data of Ru(6-Fbpb)(CO)(H2O) in nitrogen-bubbled DMF solution upon 















0 −60.9967 86469.0 0 0 0 
30 −60.9967 76304247.5 −61.0971 18192105 0.3255 
60 −61.0064 206981035.5 −61.1103 38615999 0.6339 




90 −61.0307 164325113 −61.1506 51095711 0.8335 
120 −61.0738 159379225 −61.1757 52046541 0.9463 
Chemical shifts and relative intensity of signal peak are calculated and shown in the following 
table. 
Table 3.3 Relative intensity and chemical shifts of Ru(6-Fbpb)(CO)(H2O) in nitrogen-bubbled DMF 
solution upon irradiation with light at 405 nm (10 mW/cm2) compared to the relative amount of liberated 













0 0 0 0 0 0 
30 23.8415 0 0 0.1004 0.0912 
60 18.6568 −0.0097 −0.0132 0.1039 0.8915 
90 31.0943 −0.034 −0.0535 0.1199 0.8099 
120 32.6558 −0.0771 −0.0786 0.1019 0.7437 
3.4.2. Synthesis and measurements 
Synthesis of N, N'-(1,2-phenylene)bis(X-fluoropicolinamide), ligands.  
The ligands were prepared according to the modified method by Vagg et. al. [202] The synthesis 
details and characterization analysis have been described in Chapter 2.  
Synthesis of Ru(X-Fbpb)(CO)(H2O).  
Ru(X-Fbpb)(CO) (H2O) was synthesized according to an adapted procedure Ru3(CO)12 (0.088g, 
0.14 mM) was added to a deoxygenated DMF solution of ligand (0.1452 g, 0.41 mM). The color 
of the solution turned red or brown immediately. The reaction was refluxed under nitrogen 
atmosphere for 20 h. Then the mixture was stand and cooled to room temperature. Filtering and 
washing with H2O and Et2O, a bright orange-blown solid would be collected.  





Ru(Fbpb)(CO)(H2O)   
1H NMR (400 MHz, DMSO-d6), δ (ppm): 9.02 (1H, d, J = 4.76 Hz, ArH); 8.57 (2H, d, J = 6.06 
Hz, ArH); 8.16 (1H, dt, J = 7.72 Hz, ArH); 8.15 (1H, d, J = 1.40 Hz, ArH); 7.69− 7.60 (H, m, 
ArH), 6.92 (1H, dd, J = 6.09 Hz, ArH). 13C NMR (125 MHz, DMSO-d6): δ (ppm) 165, 161, 154, 
149, 140, 128, 125, 123, 122. IR(ATR): ν =1911 cm−1 (νCO, s). ESI-MS (m/z) C19H14N4O4Ru, 
calculated for: 464, observed: 445 [Ru(bpb)(CO)(H2O)-H2O]. Elemental analysis C19H14N4O4Ru, 
calculated: C = 49.24%, H = 3.05%, Ru = 21.81%, N = 12.09 %, O = 13.81%, found: C = 48.95%, 
H = 3.39%, N = 12.81%. 
Ru(3-Fbpb)(CO)(H2O)   
1H NMR (400 MHz, DMSO-d6), δ (ppm): 8.95 (1H, d, J = 8.0 Hz, ArH); 8.57 (2H, d, J = 5.6 Hz, 
ArH); 8.26 (1H, t, J = 8.8 Hz, ArH); 8.15 (1H, d, J = 7.6 Hz, ArH); 7.43− 7.21 (3H, m, ArH). 13C 
NMR (125 MHz, DMSO-d6): δ (ppm) 164, 157, 145, 144, 128, 126, 123, 122. 19F NMR (400 
MHz, DMSO-d6,) δ (ppm): −148. IR(ATR): ν =1917 cm−1 (νCO, s) ESI-MS (m/z) C19H12F2N4O4Ru, 
calculated for: 500, observed: 454 [Ru(3-Fbpb)(CO)(H2O)- CO-H2O]. Elemental analysis 
C19H12F2N4O4Ru, calculated: C = 45.70%, H = 2.42%, F = 7.61%, Ru = 20.24%, N = 11.22%, O 
= 12.81%, found: C = 44.99%, H = 2.39%, N = 11.50%. 
Ru(5-Fbpb)(CO)(H2O) 
1H NMR (400 MHz, DMSO-d6), δ (ppm): 9.28 (1H, J = 8.0 Hz, ArH); 8.54 (2H, J = 5.6 Hz, ArH); 
8.09 (1H, , J = 8.8 Hz, ArH); 8.02 (1H, s, J = 7.6 Hz, ArH); 6.91  (3H, , ArH). 13C NMR (125 
MHz, DMSO-d6): δ (ppm) 202, 164, 163, 158, 145, 143, 142, 127, 123, 122. 19F NMR (400 MHz, 
DMSO-d6,) δ (ppm): −121.92. IR(ATR): ν =1931 cm−1 (νCO, s). ESI-MS (m/z) C19H12F2N4O4Ru, 
calculated for: 500, observed: 454 [Ru(5-Fbpb)(CO)(H2O)- CO-H2O]. 
Elemental analysis C19H12F2N4O4Ru, calculated: C = 45.70%, H = 2.42%, F = 7.61%, Ru = 
20.24%, N = 11.22%, O = 12.81%, found: C = 45.31%, H = 2.39%, N = 11.35%. 
Ru(6-Fbpb)(CO)(H2O)  
1H NMR (400 MHz, DMSO-d6), δ (ppm): 8.65 (1H, dt, J = 8.0 Hz, ArH); 8.32 (2H, m, J = 5.6 Hz, 




ArH); 7.95 (1H, d, J = 8.8 Hz, ArH); 7.64 (1H, m, J = 7.6 Hz, ArH); 6.92 (3H, dt, ArH). 13C NMR 
(125 MHz, DMSO-d6): δ (ppm) 164, 158, 147, 141, 127, 126, 121, 120. 19F NMR (400 MHz, 
DMSO-d6,) δ (ppm): −60.33. IR(ATR): ν =1923 cm−1 (νCO, s). ESI-MS (m/z) C19H12F2N4O4Ru, 
calculated for: 500, observed: 454 [Ru(6-Fbpb)(CO)(H2O)- CO-H2O]. Elemental analysis 
C19H12F2N4O4Ru, calculated: C = 45.70%, H = 2.42%, F = 7.61%, Ru = 20.24%, N = 11.22%, O 
= 12.81%, found: C = 46.07%, H = 2.39%, N = 11.12%. 




4. Fluorinated manganese CO releasing molecule  
The following section focuses on a manganese tricarbonyl photo-CORM with a 
fluorobenzenesulfonyl functional group. This CORM-FBS demonstrated a strong stability in 
aqueous buffer media under dark conditions. Upon irradiation with low intensity light, CORM-
FBS complex rapidly release almost all three CO, which were detected by myoglobin assay and 
time-dependent liquid IR spectra. Additionally, the photolysis of carbon monoxide occurred in a 
stepwise way forming mono- or dicarbonyl species with additional solvent molecules as ligands 
for further photoreaction. In this study, 19F NMR spectroscopy was employed to detect photo-
product iCORM-FBS and was confirmed applicable for quantitative evaluation CO release. This 
provides a reliable method of monitoring the photochemical activities from fluorine containing 
CO releasing molecules. 
4.1. Introduction 
4.1.1. Quantitative 19F NMR spectroscopy 
Nuclear magnetic resonance (NMR) spectroscopy has been performed to determinate of the 
substances content and products characterization because of its high speed, sensitivity and 
precision. [219] Compared to traditional 1H and 13C NMR, 19F NMR has a broader chemical shift 
range (approximately 400 ppm for organics) and high resolution to avoid signal overlap with each 
other, leading to 19F NMR is more suitable for the quantitative analysis of compound in a 
biological background. Therefore, this technology has been applied to the identification of 
molecule structures, quantitative studies of pharmaceutical agent and drug metabolism as well as 
monitoring of the reaction process. For example, Komber et al. used 19F NMR to characterize 
generated main perfluorooctanesulfonate isomers from a commercial mixture via quantification of 
the individual -CF3 branched isomers. [220] This group also reported kinetic studies on the stepped 
reaction of decafluorobiphenyl with thiophenol by employing this spectroscopy to determine rate 
constants. [221] Furthermore, Althelm and colleagues prepared a collection of fluorinated boronic 




acid-appended salts to identify and discriminate diol containing bioanalytes under physiological 
conditions. [222,223] Characteristic 19F NMR signals were processed into 2D quick response-like 
barcodes to present directly visual images and compare the interaction of receptors with analytes. 
So far, growing studies on the research methodology of 19F NMR for the quantitative analysis of 
fluorinated complexes have been reported and this spectroscopy is expected to widen the 
application scope with improving high-magnetic field NMR instrument and high-sensitivity probe.  
4.1.2. Manganese tricarbonyl CORMs 
As mentioned previously in chapter 1.2.2, the carbon-metal-oxygen bond is influenced by the π 
back-donation process which results from antibonding π* molecular orbital on the CO and the d-
orbitals of metal center. Among variety of metal carbonyl complexes, ruthenium-, iron-, rhenium-, 
and manganese-carbonyl CORMs were well studied. Ruthenium complexes are generally stable 
and require UV light to liberate CO with low quantum yield. While manganese complexes are 
much more attractive due to their 3d metal orbitals leading to a fast CO release and the Mn center 
commonly bonds with poly-carbonyl ligands. Moreover, Lehnert et al. insisted that ruthenium 
complexes were generally directly excited from a bonding dπ-π* orbital to an antibonding π*-dπ 
orbital (the single excited state). [87] The manganese complexes can undergo photolabilization by 
the direct single excited state and an indirect way which needed a higher singlet excited state of 
electron excitation corresponding to the triplet state (dxy→ π*-dπ). 
In general, a series of Lewis bases including arenes, amines and other heterocyclic moieties facile 
coordinate to manganese carbonyls to form a variety of six coordinated fac-Mn(I) tricarbonyl 
complexes. These photo-CORMs release CO when irradiated with UV to visible light. However, 
studies mainly focus on the spatially and temporally precisely controlled CO release and 
biological activity profiles in vivo, few refers the primary photophysical and photochemical steps. 
Although majority of CORMs can release almost all three coordinated carbonyl ligands, it 
remains difficult to confirm reaction occurs in a stepwise or concerted way for a long time.  
To investigate the light-triggered carbon monoxide release, Kurz et al. used two manganese (I) 
complexes Mn(CO)3(tpm)(PF6) (tpm = tris(pyrazolyl)methane) and Mn(CO)3(bpzaa) 
(bpzaa = bis(pyrazolyl)acetic acid) as representative compounds with spectroscopic methods. [224] 




They found that the manganese centers lose their carbonyl ligands in a stepwise manner and the 
dicarbonyl intermediates formed after one CO release per CORM. The remaining two carbonyl 
ligands were then liberated by oxidation to manganese (II) ultimately resulting in final reaction 
products μ-O-Mn(III) compound. This is also associated to the difference of measured CO release 
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DMSO) recorded every 30 seconds over a course 18 min. 
Two main absorption bands respectively at 260 nm and 360 nm were shown in Figure 4.3 (a). The 
former band is commonly assigned to polycyclic aromatic hydrocarbons. An indistinct shoulder 
absorption band at around 304 nm interlaced with the less intense absorption band at 360 nm was 
also observed. With illumination time increasing, the broad absorption region decreased gradually 
remaining an isosbestic point at 425 nm and the absorption band at 360 nm increased with a small 
range red-shift. This results from the metal to ligand charge transfer (MLCT) from dMn to π*py, 
corresponding to the excitation state S5–S8 at 350 nm predicted by TD-DFT calculations (ΔE = 
0.30 eV, Δλmax = 27 nm). TD-DFT estimates the excitation S1 at 400 nm with 3.10 eV, that 
corresponds to the same HOMO → LUMO transition. Moreover, DFT calculations predicts that 
CORM-FBS conformer contains three absorption bands respectively at 188 nm (ε = 3.7 × 104 
mol−1 L cm−1), 228 nm (ε = 1.3 × 104 mol−1 L cm−1) and 303 nm (ε = 3.6 × 103 mol−1 L cm−1), 
while the iCORM-FBS exhibits absorption bands in the region at 202 nm (ε = 1.4 × 104 mol−1 L 
cm−1), 232 nm (ε = 1.8 × 104 mol−1 L cm−1) and 313 nm (ε = 3.0 × 102 mol−1 L cm−1). These data 
are essentially in agreement with the spectral records.    
The photoreaction was also measured under dark conditions. No changes in absorbance were 
observed in the phosphate buffer media over a course 12 h, confirming the stability of compound 
CORM-FBS in solution environment. Additionally, time-dependent liquid-phase IR spectra for 
CORM-FBS upon exposure to light at 405 nm was performed. It is clearly to observe the 
carbonyls characteristic vibration bands at 2043 cm-1, 1957 cm-1 and 1936 cm-1 in pure DMSO 
solution decreased gradually with illumination time increasing, ultimately disappeared after 15 
min. This confirms that all three equivalents coordinated CO release. No back reaction was 
observed even when the light was turned off.     
4.2.3. Myoglobin assay for CORM-FBS and investigation of the CO-release 
mechanism 
To determinate CO release from CORM-FBS, a myoglobin assay was performed at room 
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populated by ambient solvent molecules, which can be described as a conversion from 
[MnL(CO)3] + to [MnL(solvent)3]2+. 
4.2.5. Quantitative 19F NMR analysis for CORM-FBS upon irradiation 
Time-dependent 19F NMR spectroscopy was used to monitor the photodegradation of CORM-
FBS. The first spectroscopy assay was performed at room temperature. The signal peaks became 
broader and disappeared with the illumination time increasing especially for the triflate functional 
group (-OSO2CF3) of CORM-FBS (shown in Table 4.2). This attributed to the paramagnetic 
nature of manganese(II) species. To reduce the signal linewidth, temperature series in the range of 
40 °C to −70 °C in ACN solution were applied. Spectra of 19F NMR at 40 ºC demonstrated that 
the signals completely disappeared at a faster rate than that at room temperature and detail 
information was lost (shown in Table 4.1). Low temperature was confirmed to decrease the 
influence of paramagnetism and spectra results upon illumination within 120 s were depicted in 
Figure 4.8.  
There was one initial characteristic signal peak (F1) found at −101.02 ppm of CORM-FBS in 
ACN solution before irradiation. Upon exposure to light (405 nm, 8 mW/cm2), slightly chemical 
shifts toward low-field were observed, indicating that the chemical environment of CORM 
residues has changed. Moreover, 19F NMR spectra represented that a new peak (F2) at −102.28 
ppm grew after 10 seconds irradiation and increased gradually as well as shifted to low-field. 
Then a third peak (F3) displayed at −107.60 ppm and increased with 30 seconds excitation. 
Moreover, signals of F1 and F2 disappeared after 90 seconds and 60 seconds illumination 
respectively, remaining only one characteristic peak F3 with an ultimately chemical shift ΔδF = 
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4.3. Summary and Conclusion 
In brief, a stable and water-soluble manganese-based tricarbonyl complex with a 
fluorobenzenesulfonyl group was prepared. This CORM-FBS can rapidly release almost all three 
CO molecules upon illumination with low intensity light. DFT and TD-DFT calculations gave 
insight into the CO release mechanism and the properties of the inactive CORM product. For the 
first time, 19F NMR is performed to quantitatively analysis the photoreaction process of CORM-
FBS under irradiation. Despite the paramagnetic of Mn(II) species, the comparison of 
characteristic spectra reveals that one CO ligand was firstly photochemically dissociated and 
replaced by solvent molecule with remaining residues for further CO release. The high-speed, 
good accurate and ease of measurement technology make 19F NMR spectroscopy provide a 
promising direction to monitor the process of CORM photo-degradation. We expect that with 
continuously improving quality of NMR spectrometers and mature technique, this approach for 
the detection and discrimination can be applicable to a wider scope. 
 




4.4.    Experimental section 
4.4.1. General procedure 
Materials and instrumentation.  
Mn(CO)5Br, silver triflate, di-(2-picolyl)amine, 4-fluorobenzenesulfonyl chloride and 
triethylamine were purchased from Sigma-Aldrich. Solvents were purified and/or dried by 
standard techniques prior to use for all syntheses. 1H NMR and 13C NMR were recorded on a 
Bruker AV 400 MHz NMR spectrometer in CDCl3 or DMSO-d6 at room temperature, 19F NMR 
spectra were performed in ACN-d3 at -70 °C and 40 °C. Tetramethylsilane (TMS) served as an 
internal standard for 1H NMR, and trichlorofluoromethane (CCl3F) as an internal standard for 19F 
NMR. Chemical shifts as related to the signals of the deuterated solvents used. UV-Vis absorption 
spectra were recorded with a spectrometer Specord S 600 UV-Vis from Analytic Jena. Mass 
spectra (ESI-MS) were acquired on a Finnigan MAT SSQ 710 or MAZ95XL device. Elemental 
analysis was performed on a Heraeus Vario EL III CHNS instrument. All IR (ATR) spectra were 
recorded in a range of 400−4000cm−1 on a Bruker Vertex 70 FT-IR. Electron spin resonance (ESR) 
spectra on solution samples were recorded at X-band frequencies on a Bruker Elexsys E500 
spectrometer. 
General experimental methods for UV-Vis studies.  
A 1 mM stock solution of CORM-FBS and FBS ligand were prepared in nitrogen-bubbled DMSO, 
which was used for all studies. For spectroscopic measurements, the DMSO stock solution was 
diluted with 10 mM phosphate buffer (PB, pH 7.4) to acquire a 15 µM solution in 1:99 v/v 
DMSO:PB, unless not otherwise mentioned. UV-Vis absorption spectra were recorded at room 
temperature in a quartz cuvette every 10 seconds during UV light exposure (UVP Benchtop 2 UV 
Transilluminator, ≤8 mW/ cm2). 
Photolysis Experiment.  
Solution of CORM-FBS (15 μM) in a quartz cuvette was exposed to different light sources (365 
nm and 405 nm; 8 mW/cm2) at every 20 seconds intervals to investigate the photoinduced CO-




release studies. The power of the light sources was determined with a PM100USB power meter. 
CO-release study. 
The light-induced CO-release from CORM-FBS was achieved by illumination with LED light 
(405 nm) in myoglobin assay. The irradiation experiments were performed at fixed light 
intensities (8 mW/cm2). The number of equivalents CO-release per CORM-FBS was determined 
by myoglobin assay by using the following equation. 
The volume of CORM solution and volume of myoglobin solution should be equal.   
CCO-Mb = (𝐴t540 – 𝐴0540) / [d × (𝜀 540− 𝜀0540)]                     (Equation 4.1)   
where 𝐴t540 is the absorbance at 540 nm at each timepoint t, 𝐴0540 is initial absorbance at 540 nm, 
d is pathlength of the cuvette (d = 1 cm) and ε540 (15.40 mM-1 cm-1) is the extinction coefficient at 
540 nm according to literature. [216] 𝜀0 is corrected initial extinction coefficient in phosphate buffer 
and is obtained from the following equation: 
𝜀0540= (𝐴0540) / [d × (C0 deoxy-Mb/2)]                              (Equation 4.2)   
where C0 deoxy-Mb is calculated with starting absorbance at 560 nm Adeoxy-Mb560 and extinction 
coefficient 𝜀560 (13.80 mM-1 cm-1) at 560 nm. The calculated Mb-CO concentration was plotted 
against the illumination time. The calculated CO-Mb concentration divided by the CORM-FBS 
concentration to get the number of CO equivalents released per mole of CORM-FBS. 
19F NMR analysis for CORM-FBS upon irradiation. 
19F NMR spectra of CORM-FBS were recorded AV 400 MHz Bruker NMR spectrometer at room 
temperature, 40 °C and −70 °C respectively, using CD3CN as the solvents with 
trichlorofluoromethane (CCl3F) as an internal standard. 
Table 4.1 Characteristic peak data of CORM-FBS in nitrogen-bubbled CD3CN solution upon irradiation 
with light at 405 nm (8 mW/cm2) performed at 40 °C. Signal disappeared after irradiated 45 s due to the 

















0 −100.6226 741695.78 0 0 0 
10 −100.6279 789885.01 −101.9464 88239.06 11.1711273 
20 −100.6275 309358.94 −101.9558 49856.18 16.11596549 
30 −100.6261 399194.96 −101.9531 100040.21 25.06048924 
45 −100.619 188964.13 −101.9366 48476.63 25.65387939 
Table 4.2 Characteristic peak data of CORM-FBS in nitrogen-bubbled CD3CN solution upon irradiation 















0 −100.697 2956904.45 0 0 -- -- 
10 −100.7034 1477084.25 −101.9814 128780.2 -- -- 
20 −100.7 1998922.92 −101.9836 420688.28 -- -- 
30 −100.6996 2073539.98 −101.9836 420688.28 −107.6003 57718.45 
45 −100.7094 655307.26 −101.9947 247305.3 −108.2003 127448.68 
60 -- -- -- -- −108.0652 5158.42 
75 -- -- -- -- −108.2018 222186.8 
90 --   -- -- -- −108.1866 108394.8 
Table 4.3 Characteristic peak data of CORM-FBS in nitrogen-bubbled CD3CN solution upon irradiation 
with light at 405 nm (8 mW/cm2) performed at −70 °C compared to the amount of liberated CO recorded 















0 −101.0243 86468.95 0 0 -- -- 
10 −101.0166 45268.44 −102.2754 8051.7 -- -- 
20 −101.0185 39371.75 −102.2572 7737.81 -- -- 
30 −100.7636 763264.27 −102.0364 117282.34 −107.6003 57718.45 
45 −100.764 378552.17 −102.0363 61555.86 −107.3821 64773.58 




60 −100.7638 173039.42 -- -- −107.4524 51377.81 
75 −100.7508 69248.38 -- -- −107.2014 40683.71 
90 -- -- -- -- −107.3491 25390.98 
120 -- -- -- -- −107.4126 42854.8 
4.4.2. Synthesis and measurements 
Synthesis of 4-fluoro-N, N-bis(pyridine-2-ylmethyl)benzenesulfonamide (ligand).  
Di-(2-picolyl) amine (154 mg, 0.77 mmol) and 4-fluorobenzenesulfonyl chloride (150 mg, 0.77 
mmol) were dissolved in 25 mL of dry chloroform (CHCl3). To this solution, triethylamine (0.14 
ml) was added and stirred for 5 h at room temperature. The crude mixture was concentrated and 
subjected to alumina column chromatographic (eluent ethyl acetate and n-hexane in 2:3 (v/v)) 
purification to result pure oil compound ligand (185 mg, 52%) after evaporation of the solvent.  
1H NMR (400 MHz, CDCl3), δ (ppm): 8.39 (2H, d, J = 4.4 Hz, ArH); 7.84 (2H, J = 8.8 Hz, ArH); 
7.56 (2H, t, J = 7.5 Hz, ArH); 7.34 (2H, d, J = 7.7 Hz, ArH); 7.14 (2H, d, J = 7.8 Hz, ArH); 7.12 
(1H, d, J = 8.6 Hz, ArH); 7.11 (1H, t, J = 3.2 Hz, ArH); 4.62 (4H, s, CH2). 13C NMR (100 MHz, 
CDCl3): δ (ppm) 166.23, 163.70, 156.09, 149.14, 135.95, 135.92, 130.15, 130.06, 116.13, 115.91 
and 53.59. 19F{1H} NMR (188 MHz, CDCl3), δ(ppm): −105.61. 
Synthesis of [MnL(CO)3](CF3SO3); CORM-FBS.  
In the dark conditions and under a nitrogen atmosphere, Mn(CO)5Br (82.2 mg, 0.30 mmol) and 
silver triflate (76.8 mg, 0.30 mmol) were dissolved in 15 mL dry acetone. The reaction mixture 
was stirred at 60 °C for 1.5 h. The reaction mixture was filtered under an inert atmosphere to 
separate the precipitate of silver bromide. To the filtrate, ligand (90 mg, 0.252 mmol) in 10 mL of 
dry and deoxygenated acetone was added and the reaction mixture was heated under reflux for 
60 °C for 1.5 h. The reaction mixture was filtered off and washed with dry diethyl ether for 
several times to get pure CORM-FBS as a yellow solid (163 mg, 98%). Slow diffusion of ether 
into a CHCl3 solution of CORM-FBS afforded yellow needle-like crystals suitable for X-ray 
crystallography.  
1H NMR (400 MHz, CDCl3), δ (ppm): 8.84 (2H, d, J = 5.3 Hz, ArH); 8.13 (2H, s, ArH); 7.83 (2H, 




s, ArH); 7.64 (2H, s, ArH); 7.52 (2H, s, ArH); 7.38 (2H, t, J = 6.1 Hz, ArH); 5.15 (2H, d, J = 15.9 
Hz, CH2); 4.66 (2H, d, J = 16.4 Hz, CH2). 13C NMR (125 MHz, CDCl3), δ (ppm): 169, 167, 159, 
152, 140, 134, 133, 126, 124, 119, 118, 62 and 31. 19F{1H} NMR (188 MHz, CDCl3), δ(ppm): 
−78.17, −96.80. ESI-MS (m/z) C22H19F4MnN3O8S3-, calculated for: 648, observed: 496 [CORM-
FBS - OSO2CF3]. IR (ATR)ν = 2037 cm−1 and 1928 cm−1. Elemental analysis C30H26F3MnN6O8S2 
calculated: C = 40.75%, H = 2.95%, F = 11.72%, Mn = 8.47%, N = 6.48%, O = 19.94%, S = 
9.89%, found: C = 40.67%, H = 2.97%, N = 6.25%, S = 9.74 %. 
Crystal Data 2 for CORM-FBS:  
 C25H24F3MnN3O10S2 [*]3, Mr = 721.53 gmol-1[*], size 0.12 x 0.09 x 0.09 mm3, space group P ī, a 
= 7.3643 (2), b = 14.0144 (4), c = 14.5978 (4) Å, α = 78.6520 (10) °, β = 81.8400 (10) °, γ = 
88.2530 (10) °, V = 1462.17 (7) Å3, T= -140 °C, Z = 2, ρcalcd. = 1.639 gcm-3[*], µ (Mo-Kα) = 
0.681 mm-1[*], multi-scan, transmin: 0.9240, transmax: 0.9400, F(000) = 736 [*], reflections in 
h(-9/7), k(-18/18), l(-18/17), measured in the range 2.26° ≤ Θ ≤ 27.48°, completeness Θmax = 
98.9%, 6631 independent reflections, Rint = 0.0192, 16315 reflections with I > 2σ(I), 408 
parameters, 0 restraints, R1obs = 0.0332, wR2obs = 0.0753, R1all = 0.0357, wR2all = 0.0777, GOOF 
= 1.073, largest difference peak and hole: 0.397 / -0.438 e Å-3.  
                                                 
2 All single crystal X-Ray analysis in the dissertation were investigated by  Dr. Helmar Görls. 
3 [*]: derived parameters do not contain the contribution of the disordered solvent. 




5. Light-responsive paper strips as CO releasing material  
The following section focuses on a novel manganese tricarbonyl photo-CORM with a strong 
colorimetric response upon illumination. This CORM-Dabsyl represented excellent stability in 
aqueous media under dark conditions and could be triggered by low intensity light to release CO. 
Meanwhile, the photochemical process was conveniently observed with the naked eye by the 
associated color change. CORM-Dabsyl was loaded on paper strips and these paper strips also 
achieved CO liberation upon exposure to light with a colorimetric response. It is the first time to 
use easily disposable and low-cost paper strips as a carrier to release CO. In addition, the ease of 
preparation and the dramatic difference of color allow this strategy a potential CO releasing 
material applicable for controlled drug delivery to biological targets.  
5.1. Introduction 
5.1.1. The introduction of dabsyl chromophore 
Metal carbonyl complexes have gained increasing attention for quite long time as CO donors in 
biological systems. Alteration of the coordinated ligand frame is a promising strategy to develop 
novel CO releasing molecules. In this present work, a colorimetric dabsyl group was introduced. 
In the CORM-Dabsyl complex, the N,N’-dimethyl azo sulfonamide group was tethered to di-(2-
picolyl)amine to form a symmetrical tridentate carbonyl ligand, which coordinated facially to 
manganese center. This conjugation promoted to present a visible color change from red to yellow 
upon irradiation, which resulted from a strong intramolecular charge transfer (ICT) in excited 
states. It is conveniently to examine CO liberation with the naked eye.  
5.1.2. Evaluation CO release from CORMs under solvent free conditions 
Besides myoglobin assay described in Chapter 3, diverse approaches are applied to determination 
CO release form CORMs, such as gas chromatography, IR spectroscopy and electrochemical 
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oxygen, purple = manganese and yellow = sulphur. (c) IR spectrum of CORM-Dabsyl. 
The analytical and spectroscopic data confirmed the successful synthesis and purity of ligand 
and CORM-Dabsyl. The solid-state X-ray crystal structure of CORM-Dabsyl (Figure 5.2 b) 
shows that there are three carbonyl ligands facially coordinated to the Manganese (I) center and 
opposite to the facially coordinated dipicolyl amine moiety. Based on literature, the Mn–N (sp2) 
bond distances are generally in the range from 2.050(4) Å to 2.052(4) Å. While in the architecture, 
the Mn–N(sp3) bond length was found to be unusually longer (2.161(3) Å) due to the superior 
coordinating ability of the sp2 hybridized pyridine nitrogens compared to the sp3 hybridized amine. 
The IR spectrum of CORM-Dabsyl displayed two asymmetric νCO bands at 2037 and 1928 cm−1, 
which confirms the exist of three bonded CO. Furthermore, comparison of 1H NMR spectra 
of ligand and CORM-Dabsyl shows that the methylene protons of the dipicolylamine moiety have 
singlet multiplicity for ligand and become two doublets for CORM-Dabsyl, which is explained by 
the fact that one pair projects towards and the other pair projects away from the carbonyl ligands 
mentioned in chapter 4. [225]   
5.2.2. UV-Vis evaluation of ligand and CORM-Dabsyl under illumination 
A comparison experiments of ligand and CORM-Dabsyl was performed at 405nm until no further 
spectral changes were observed. The electronic absorption spectra were measured in aqueous 
phosphate buffer (PB): DMSO (99:1, v/v) solution and compared to calculated spectra obtained 
by the TD-DFT (Figure 5.3 a).  
Ligand L shows a strong absorption band at 415 nm (ε = 3.2 × 104 mol−1 L cm−1), which is 
assigned to an intramolecular charge transfer (ICT) process from the N, N′-dimethylamine donor 
moiety to the azo (–N=N–) fragment by means of quantum chemical simulations. Moreover, TD-
DFT predicts a bright state (S2) at 424 nm that corresponds to the HOMO → LUMO ICT-
transition on the dabsyl moiety. CORM-Dabsyl exhibits an intense absorption band in the visible 
region at 500 nm (ε = 3.3 × 104 mol−1 L cm−1). TD-DFT estimates the bright excitation (S0–S2) at 
464 nm, that corresponds to the same HOMO → LUMO transition, but with a distinct redshift 
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of irradiation time. (b) Pictures of the solution in a cuvette before (left) and after (right) the photoreaction. 
The photoreaction was also measured in phosphate buffer (99:1, PB:DMSO, v/v), which can be 
assumed that the photoreaction quantum yield is similar in phosphate buffer and in neat DMSO 
because of the similar reaction rate. Both the ligand and CORM-Dabsyl are stable and no changes 
in absorbance were observed in the phosphate buffer under dark conditions for longer than 12 h. 
This proves the exceptional stability of the two compounds in solution on the part of oxidation 
and decomposition. Moreover, there were also no spectral observed of only ligand L under 
irradiation at 405 nm in PB solution, which weakens the possible effect on the observed 
absorption changes of UV-Vis spectra upon irradiation of CORM-Dabsyl resulting from photo-
induced trans–cis isomerization. From these data, a photoreaction quantum yield of 0.5 ± 0.1% 
was calculated. The absorbance at 490 nm was observed decrease with a similar initial reaction 
rate, however, the precipitation of the photoproduct in this medium inhibited the further accurate 
study on photoreaction.  
5.2.3. Myoglobin assay for CORM-Dabsyl and investigation of the CO-release 
mechanism 
To determinate CO release from CORM-Dabsy, a very common technique myoglobin assay based 
on the spectral changes in absorption was applied. A freshly prepared concentrated solution of 
CORM-Dabsyl in oxygen-free DMSO was added to a buffered solution of horse skeletal 
myoglobin (Mb), and small excess sodium dithionite was added to capture the trace of incoming 
oxygen to prevent reaction with reduced myoglobin. Upon illumination of this mixture with light 
(405 nm, 8 mW cm−2), the absorbance of deoxy-Mb at 557 nm decreased and the characteristic 
absorbance bands of Mb–CO at 540 and 577 nm grew and stabilized after 4 min, thereby 
confirming the binding of CO to Mb. In addition, a further same component myoglobin assay 
solution was kept in the dark for 60 min, to demonstrate the influence of sodium dithionite on 
CO-release from CORM-Dabsyl (Figure 5.5 a). The characteristic absorbance band did not 
decrease distinctly and no absorbance changes at 540 and 577 nm were observed. This confirms 
not only the stability of CORM-Dabsyl in the myoglobin solution under dark conditions, but also 
the stability against sodium dithionite. Hence, the release of CO was induced by light illumination 




and not by the sodium dithionite. Thus, these data manifest CO release from CORM-Dabsyl upon 
irradiation at 405 nm. The amount of CO per CORM was calculated from these data and 
amounted to the near-complete release of three equivalents CO for each molecule CORM-Dabsyl 
(Figure 5.5). The previously calculated photoreaction quantum yield was therefore multiplied by 
3, which gave a quantum yield of CO-release of 1.5 ± 0.2% (with 424 nm irradiation). 
 
Figure 5.5 Conversion of deoxy-Mb to Mb–CO in a mixture of CORM-Dabsyl (15 μM) and deoxy-Mb (60 
μM) in phosphate buffer (pH 7.4) upon exposure to light (405 nm, 8 mW/cm2). Inset: CO release per 
CORM-Dabsyl versus time. 
To identify which molecular orbitals are associated to the photochemical release of CO upon blue 
light illumination, TD-DFT calculations were performed. Several excited states were identified 
between 418 and 396 nm that correspond to excitations from the three (Mn–CO)-bonding dπ-
orbitals, responsible for π-back bonding to CO, to (Mn–CO)-antibonding orbitals. While the dπ-
orbitals feature mainly d-character, the MOs 167 and 168 correspond to antibonding linear 
combinations between π*CO- and the eg-orbitals. [227] These data indicate that the photochemical 
activity of CORM-Dabsyl originates from orbitals around the Mn center and not start from ligand 
excited states that are populated with light above 418 nm (up to 600 nm). Even though there was 
a strong absorption of CORM-Dabsyl upon excitation with 480 nm light (Figure 5.6 b), no CO 
release is observed at all. This is considered as the absorption band of the dabsyl moiety in 
CORM-Dabsyl.  





Figure 5.6 (a) Electronic absorption spectral traces of CORM-Dabsyl (15 M) in presence of sodium 
dithionite and myoglobin (60 M) recorded at dark conditions for every 10 min intervals in nitrogen 
bubbled phosphate buffer (PB: DMSO = 99:1, v/v, pH 7.4). (b) Electronic absorption spectral of CORM-
Dabsyl irradiated with 480 nm light (8 mW/cm2) recorded for every 20 sec intervals in phosphate buffer 
(PB: DMSO = 99:1, v/v, pH 7.4). 
This result confirms that the complex only reacts with deep-blue light and that the photo-induced 
liberation of CO is not influenced by the colorimetric functional group dabsyl moiety. Whereas, 
the CT character of ligand intensely contributes to the charge distribution in vicinity of the 
manganese metal center (electronic ground state). Overall, it is established that CORM-Dabsyl is 
a highly stable CORM and that CORM-Dabsyl releases almost all three carbonyls under 
irradiation with low intensity light, concomitantly a remarkable colorimetric response. 
5.2.4. Characterization of the inactive product after irradiation. 
Diverse characterization approaches (such as ESR, NMR, IR spectroscopy, MS and DFT 
calculations) are performed to investigate the photo-product iCORM-Dabsyl.  13C NMR 
spectroscopy demonstrated that the signal peak at 217.8 ppm for the CO molecules of CORM-
Dabsyl disappeared upon irradiation of CORM-Dabsyl, which confirmed the successful CO 
release of CORM (Figure 5.7 b). 1H NMR spectroscopy of photo-product manifested that the 
ligand L still combined with the Mn center through the observed proton signals without chemical 
shift (Figure 5.7 a). However, the broader signal peaks upon illumination compared to the initial 
CORM-Dabsyl exhibited the paramagnetic nature of the product, which is related to the oxidation 
status of manganese. Moreover, the comparison of X-band ESR spectrum (at 295 K) proved this 
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5.3. Summary and conclusion 
In conclusion, a stable and water-soluble colorimetric CO-releasing molecule (CORM-Dabsyl) 
that releases three CO molecules upon photolysis is synthesized. The associated color change is 
easily observed by the naked eye. DFT and TD-DFT calculations are performed to investigate the 
CO release mechanism, contribution of dabsyl ligand and the properties of the photo-product 
iCORM-Dabsyl. Moreover, paper strips based on CORM-Dabsyl that acted as a CO-releasing 
material for convenient and efficient CO-release under illumination are the first time fabricated. 
The strong colorimetric response offers a direct visible estimation of CO release. The 
confinement of CORM-Dabsyl into paper strips allows on-demand release of CO at a biological 
site and the retention of mild toxic metal photo-product fragments. This study paves the way for 
the development of the next generation of CO-releasing materials. 
 




5.4.    Experimental section 
5.4.1. General procedure 
Materials and instrumentation.  
Mn(CO)5Br, silver triflate, di-(2-picolyl)amine, dabsyl chloride and triethylamine were purchased 
from Sigma-Aldrich. Solvents were purified and/or dried by standard techniques prior to use for 
all syntheses. 1H NMR, 13C NMR and 19F NMR spectra were recorded on a Bruker AV 400 MHz 
NMR spectrometer in CDCl3 or DMSO-d6 at room temperature. Tetramethylsilane (TMS) served 
as an internal standard for 1H NMR, and trichlorofluoromethane (CCl3F) as an internal standard 
for 19F NMR. Chemical shifts as related to the signals of the deuterated solvents used. UV-Vis 
absorption spectra were recorded with a spectrometer Specord S 600 UV-Vis from Analytic Jena. 
Mass spectra (ESI-MS) were acquired on a Finnigan MAT SSQ 710 or MAZ95XL device. 
Elemental analysis was performed on a Heraeus Vario EL III CHNS instrument. All IR (ATR) 
spectra were recorded in a range of 400 – 4000 cm-1 on a Bruker Vertex 70 FT-IR. Electron spin 
resonance (ESR) spectra on solution samples were recorded at X-band frequencies on a Bruker 
Elexsys E500 spectrometer. 
General experimental methods for UV-Vis studies.  
A 1 mM stock solution of CORM-Dabsyl and Dabsyl ligand were prepared in nitrogen-bubbled 
DMSO, which was used for all studies. For spectroscopic measurements, the DMSO stock 
solution was diluted with 10 mM phosphate buffer (PB, pH 7.2) to acquire a 15 µM solution in 
1:99 v/v DMSO: PB, unless not otherwise mentioned. UV-Vis absorption spectra were recorded at 
room temperature in a quartz cuvette every 20 seconds during UV light exposure (UVP Benchtop 
2 UV Transilluminator, ≤8 mW/ cm2). 
Photolysis Experiment.  
Solution of CORM-Dabsyl (15 μM) in a quartz cuvette were exposed to different light sources 
(365 nm, 405 nm and 480 nm; 8 mW/cm2) at every 20 seconds intervals to investigate the 
photoinduced CO-release studies. The power of the light sources was determined with a 




PM100USB power meter. 
Calculation of the quantum yield of photoactivation.  
A solution of CORM-Dabsyl in DMSO (50 µM, volume V = 3.0 mL) was transferred to a stirred 
quartz fluorescence cuvette (1 cm pathlength) at 20 °C in a UV-Vis absorption spectrometry setup. 
Irradiation was performed with a high power 424 nm fiber-coupled LED (Thorlabs M420F2) that 
was connected to a collimating lens on top of the cuvette, thereby producing a 23.3 mW light 
beam through the solution (i.e. photon flux Ф = 8.26 × 10-8 Einstein/s). UV-Vis spectra were 
recorded every second until the reaction was completed. The quantum yield (φ) of the 
photochemical reaction of CORM-Dabsyl was then calculated according to Equation 5.2. [230] It 
was assumed that the photoreaction proceeds with pseudo-first order kinetics, which is justified 
by the fact that we observe the spectral evolution of one species to the other without any 
intermediates.  
φ = 𝑘 × 𝑛𝑡𝑜𝑡 / [Φ × (1 − 10Aexc)]                                (Equation 5.2) 
where k is the reaction rate constant, 𝑛𝑡𝑜𝑡 is the total amount of manganese complex in solution, 
and Aexc is the absorbance at the selected excitation wavelength (424 nm in this section). k was 
obtained from the slope of a plot of ln([CORM-Dabsyl]/(ntot/V)) versus irradiation time, where 
[CORM-Dabsyl] was obtained at each timepoint i according to Equation 5.3:  
[𝑪𝑶𝑹𝑴– 𝑫𝒂𝒃𝒔𝒚𝒍] = (𝐴𝑖487 − 𝐴∞487) / [𝑙 × (𝜀𝐶𝑂𝑅𝑀−𝐷𝑎𝑏𝑠𝑦𝑙 487 − 𝜀𝑝𝑟𝑜𝑑𝑢𝑐𝑡 487)]   (Equation 5.3) 
where 𝐴𝑖 487 is the absorbance at 487 nm at each timepoint i or at the end of the reaction (∞) and 
ε487 is the extinction coefficient at 487 nm (3.4 × 104 and 1.3 × 104 for CORM-Dabsyl and the 
photoproduct, respectively). φ had a value of 0.5% ± 0.1% under 424 nm irradiation. Since the 
photoreaction is accompanied by the release of three carbonyls, the quantum yield of CO-release 
was 1.5 ± 0.2% under 424 nm irradiation. 
5.4.2. Synthesis and measurements 
(E)-4-((4-(dimethylamino)phenyl)diazenyl)-N,N-bis(pyridin-2-ylmethyl)benzenesulfonamide 
(ligand).  




Di-(2-picolyl) amine (105 mg, 0.5 mmol) and dabsyl chloride (162 mg, 0.5 mmol) were dissolved 
in 25 mL of dry tetrahydrofuran (THF). To this solution, triethylamine (0.1 ml) was added and 
stirred for 5 h at room temperature. A red-colored precipitate was filtered. The filtrate was 
concentrated and subjected to silica column chromatographic (eluent ethyl acetate and hexane in 
1:1 (v/v)) purification to yield pure ligand as a red solid (150 mg, 61%).  
1H NMR (400 MHz, CDCl3), δ (ppm): 8.39 (2H, d, J = 4.4 Hz, ArH); 7.94−7.87 (6H, m, ArH); 
7.57 (2H, t, J = 7.2 Hz, ArH); 7.35 (2H, d, J = 7.6Hz, ArH); 7.10 (2H, t, J = 5.2 Hz, ArH); 6.79 
(2H, d, J = 9.2Hz, ArH); 4.66 (4H, s, CH2); 3.15 (6H, s, CH3). 13C NMR (100 MHz, DMSO-d6): δ 
(ppm) 156.28, 155.50, 149.07, 143.61, 139.24, 136.52, 128.32, 125.72, 122.64, 122.46, 122.28, 
111.47, 53.78 and 46.30. ESI-MS (m/z) C26H26N6O2S calculated: 486.18, observed: 509.2 
[M+Na]+. 
Synthesis of [MnL(CO)3](CF3SO3), CORM-Dabsyl.  
In the dark conditions and under a nitrogen atmosphere, Mn(CO)5Br (110 mg, 0.40 mmol) and 
silver triflate (120 mg, 0.40 mmol) were dissolved in 15 mL dry acetone. The reaction mixture 
was stirred at 60 °C for 1.5 h. The reaction mixture was filtered under an inert atmosphere to 
separate the precipitate of silver bromide. To the filtrate, ligand (150 mg, 0.31 mmol) in 10 mL of 
dry and deoxygenated acetone was added and the reaction mixture was heated under reflux for 
60 °C for 1.5 h. The reaction mixture was filtered off and washed with dry diethyl ether for 
several times to get pure CORM-Dabsyl as a dark red solid (180 mg, 74%). Slow diffusion of 
ether into a CHCl3 solution of CORM-Dabsyl afforded orange red plate-like crystals suitable for 
X-ray crystallography.  
1H NMR (400 MHz, DMSO-d6), δ (ppm): 8.95 (1H, d, J = 8.0 Hz, ArH); 8.84 (2H, d, J = 5.6 Hz, 
ArH); 8.62 (1H, t, J = 8.8 Hz, ArH); 8.46 (1H, d, J = 7.6 Hz, ArH);7.44− 7.78 (3H, m, ArH); 7.67 
(1H, t, J = 8.0 Hz, ArH); 7.48 (2H, d, J = 7.6 Hz, ArH); 7.37 (2H, t, J = 6.0 Hz, ArH); 7.27 (1H, d, 
J = 8.8 Hz, ArH); 5.22 (2H, d, J = 16.4 Hz, CH2); 4.35 (2H, d, J = 16.4 Hz, CH2); 3.00 (6H, s, 
CH3). 13C NMR (125 MHz, DMSO-d6), δ (ppm): 217, 159, 157,154, 143, 140, 133, 127, 126, 126, 
124, 123, 112, 63 and 29. 19F{1H} NMR (188 MHz, DMSO-d6), δ(ppm): −77.89. ESI-MS (m/z) 
C31H26F3MnN6O8S2-, calculated for: 774, observed: 625 [CORM-Dabsyl - OSO2CF3]. IR (ATR)ν 
= 2037 cm−1 and 1928 cm−1. Elemental analysis C30H26F3MnN6O8S2 calculated: C = 46.52%, H = 




3.38%, F = 7.36%, Mn = 7.09%, N = 10.85%, O = 16.52%, S = 8.28%, found: C = 46.07%, H = 
3.39%, N = 10.50%, S = 8.03 %. 
Crystal Data for CORM-Dabsyl:  
C31H30F3MnN6O9S2[*], Mr = 806.67 gmol-1[*], orange prism, size 0.134 × 0.122 × 0.108 mm3, 
triclinic, space group P ī, a = 10.5628(2), b = 13.4613(3), c = 26.2818(5) Å, α = 79.225(1), β = 
83.349(1), γ = 75.404(1)°, V = 3543.33(12) Å3, T= −140 °C, Z = 4, ρcalcd. = 1.512 gcm-3[*], µ 
(Mo-Kα) = 5.67 cm-1[*], multi-scan, transmin: 0.6886, transmax: 0.7456, F(000) = 1656[*], 
26160 reflections in h(-13/13), k(-17/17), l(-33/33), measured in the range 1.58° ≤ Θ ≤ 27.10°, 
completeness Θmax = 95.9%, 15002 independent reflections, Rint = 0.0266, 12901 reflections 
with Fo > 4σ(Fo), 925 parameters, 0 restraints, R1obs = 0.0867, wR2obs = 0.2193, R1all = 0.0985, 
wR2all = 0.2279, GOOF = 1.041, largest difference peak and hole: 2.815 / −3.716 e Å-3.  




6. Colorimetric and fluorometric responsive photo-CORM  
This chapter describes a novel manganese tricarbonyl photo-CORM with a colorimetric as well as 
fluorometric response upon irradiation with visible light. This CORM-NBD demonstrated 
superior stability in aqueous environment under normal day light conditions. Upon exposure to 
light with low intensity (at 490 nm), CORM-NBD releases almost all three CO with a visible 
color change from colorless to yellow as well as a strong luminescent response that centered at 
560 nm. The associated colorimetric response gives a visible instant feedback of whether CO has 
been released and the turn-on luminescence makes it possible to track the CO delivery 
intracellular conditions. Additionally, TLC plates that loaded CORM-NBD complexes rapidly 
released CO under illumination. In vitro studies, LX-2 and HepaRG® human cell lines were used, 
which confirmed a low toxicity of CORM-NBD against the two cell lines. These results render 
CORM-NBD a novel CO releasing material to photodynamic therapy (PDT).  
6.1. Introduction 
6.1.1. The introduction of NBD group 
Series of luminescent Mn(I)- and Re(I)- based carbonyl complexes as trackable photo-CORMs 
for CO delivery to cellular targets are published by Mascharak et al. [231–234] These photo-CORMs 
were proved to release CO upon exposure to light in human breast cancer cells or human colon 
cancer cells leading to a dose-dependent apoptotic cell death, and the turn-on luminescence 
promoted to track photolysis of CORMs within the cellular matrices. Inspired by those works, a 
nitrobenzodiazole (NBD) fluorophore with dual colorimetric as well as fluorometric response was 
used to increase the conjugation in the ligand, leading to absorption in the visible spectrum. This 
functional group was tethered to di-(2-picolyl)amine to form a symmetrical tridentate carbonyl 
ligand, which can coordinate facially to a manganese center. Upon illumination, fluorometric 
response occurs with visible color change due to photo-release of CO from CORM-NBD. 




6.1.2. Biological studies of CO releasing molecules 
The first step to develop a desired drug is commonly to identify a molecular target for the   
treatment of a selected disease. However, there is no identified definite molecule target or specific 
signaling pathways for carbon monoxide. Therefore, the biological studies of CORMs as drug 
agents need to be performed within cellular substrate with animal models of human diseases. [169] 
Mostly of biological applications of CO and CORMs focus on the inflammatory diseases, 
cardiovascular models and cancer cells. Inflammatory diseases generally start with the activation 
of macrophages and CORMs can be tested ex vivo with isolated macrophages or with macrophage 
cell lines. For instance, CORM-3 was tested in joint tissues and was proved to decrease the 
inflammatory response through increasing the levels of osteocalcin in the serum but also to 
protect against the degradation of cartilage and bone. [235] In cardiovascular disease models, 
CORMs are designed to exhibit protection of cells against death or accelerate specific endothelial 
cell proliferation. Chen et al. used CORM-2 to rescue OH-1-deficient mice from arterial 
thrombosis by reducing platelet aggregation in the graft. [236] Cancer cell experiments often use 
generated CO to inhibit cancer cell growth and induce apoptosis in cancer cells in a dose-
dependent manner or time-dependent manner. [237] In this present work, parenchymal hepatocyte-
like cell line HepaRG® and non-parenchymal hepatic stellate cell-like cell line LX-2 were used 
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NBD-CORM for 30 min at 37 °C (λex = 488 nm; λem = 555 nm: (a,c) bright-field images, (b) image without 
light exposure and (d) image recorded after irradiation with low power LED light (λirr = 470 nm). Cell 
viability of LX-2 cells in percentage for e) NBD-CORM and f) NBD-iCORM (NEG = non-treated, POS = 
0.05 % sodium dodecyl sulphate). 
In vitro experiments revealed that CORM-NBD was no cytotoxic to both cell lines even with up 
to a concentration of 250 μM or higher. While for iCORM-NBD against HepaRG®, a reduction 
of viability was found at a concentration of 250 μM or higher, resulting in more than 30 % cell 
viability loss. The CO-depleted molecule showed remarkable toxicity only at the highest tested 









6.3. Summary and Conclusion 
In conclusion, a colorimetric as well as fluorometric dual response CO-releasing molecule 
(CORM-NBD) that releases all three CO molecules upon photolysis at low energy light is 
introduced. The easily observed colorimetric response provides a directly visible estimation of 
CO release by the naked eye. The turn-on luminescence achieves to track the CO delivery within 
the cells from the cellular imaging experiments on LX-2 cells and HepaRG® cells. DFT and TD-
DFT calculations are studied to investigate the CO release mechanism. Moreover, TLC plate 
sticks that loaded CORM-NBD release CO immediately under illumination with strong 
colorimetric response. These make CORM-NBD a promising candidate to conduct as CO 
releasing material in therapeutic application. 
 




6.4. Experimental section 
6.4.1. General procedure 
Materials and instrumentation.  
Mn(CO)5Br, silver triflate, di-(2-picolyl)amine, 4-chloro-7-nitrobenzofurazan and fluorescein 
were purchased from Sigma-Aldrich. Solvents were purified and/or dried by standard techniques 
prior to use for all syntheses. 1H NMR, 13C NMR and 19F NMR spectra were recorded on a 
Bruker AV 400 MHz NMR spectrometer at room temperature using CDCl3, CD3CN and DMSO-
d6 as the solvents. Tetramethylsilane (TMS) and trichlorofluoromethane (CCl3F) were used as 
internal standards for 1H NMR and 19F NMR, respectively. Chemical shifts as related to the 
signals of the deuterated solvents used. UV-Vis absorption spectra were recorded with a 
spectrometer Specord S 600 UV-Vis from Analytic Jena. Mass spectra (ESI-MS) were acquired 
on a Finnigan MAT SSQ 710 or MAZ95XL device. Mass spectra were acquired on a Finnigan 
MAZ95XL device. Elemental analysis was performed on a Vario EL III CHNS instrument. All IR 
(ATR) spectra were recorded on a Bruker Vertex 70 FT-IR spectrometer. Electron spin resonance 
(ESR) spectra on solution samples were recorded at X-band frequencies on a Bruker Elexsys 
E500 spectrometer. 
General experimental methods for UV-Vis and fluorescence studies.  
A 1 mM stock solution of CORM-NBD and ligand L were prepared in nitrogen-bubbled DMSO, 
which was used for all the studies. Unless not otherwise mentioned, the DMSO stock solution 
was diluted with 10 mM phosphate buffer (PB, pH 7.2) and the diluted solution was used for all 
spectroscopic studies. For spectroscopic measurements, DSMO stock solution was further diluted 
with phosphate buffer (PB: DMSO, 99:1, v/v) and the effective final concentration was made as 
10 μM. All luminescence measurements were done using λex = 440 nm with an emission slit width 
of 3 nm. The fluorescence quantum yield was determined according to literature method using 
fluorescein (in 0.1 M NaOH) as reference (Φf = 0.92). Each spectrum was recorded at room 
temperature with a quartz cuvette at regular time intervals of UV light exposure (UVP Benchtop 2 




UV Transilluminator, ≤10 mW/cm2) at different wavelengths. 
Photolysis Experiment.  
Solution of CORM-NBD (15 μM) in a quartz cuvette were exposed to different light sources (365 
nm, 405 nm and 480 nm; 8 mW/cm2) at every 20 sec intervals to investigate the photoinduced 
CO-release studies. The power of the light sources was determined with a PM100USB power 
meter. 
Calculation of the quantum yield of photoactivation.  
A solution of 8.3 µM CORM-NBD in 1/99 DMSO/PBS (v/v, V = 3.0 mL) was transferred to a 
stirred quartz fluorescence cuvette (1 cm pathlength) at 20 °C in a UV-Vis absorption 
spectrometry setup. Irradiation was performed with different wavelength LEDs (365, 413, 450, 
and 490 nm) that were mounted on top of the cuvette using a custom-build holder that fit exactly 
on top of the cuvette. Photon fluxes (Ф) were determined by ferrioxalate actinometry and had 
values of 1.9 × 10–8, 2.2 × 10–8, 1.3 × 10–7, and 6.1 × 10–8 einstein/s at 365, 413, 450, and 490 nm, 
respectively. UV-Vis spectra were recorded every second until the reaction was completed. The 
quantum yield (φ) of the photochemical reaction of CORM-NBD was then calculated according 
to the following equation. [209] It was assumed that the photoreaction proceeds with pseudo-first 
order kinetics, which is justified by the fact that we observe the spectral evolution of one species 
to the other without any intermediates.  
φ = 𝑘 × 𝑛𝑡𝑜𝑡 / [Φ × (1 − 10Aexc)]                            (Equation 6.1) 
where k is the reaction rate constant, 𝑛𝑡𝑜𝑡 is the total amount of manganese complex in solution, 
and Aexc is the absorbance at the selected excitation wavelength. k was obtained from the slope of 
a plot of ln([CORM-NBD]/(ntot/V)) versus irradiation time, where [CORM-NBD] was obtained at 
each timepoint i according to a method reported by Bahreman to deconvolute the two species’ 
concentrations in time using the molar absorption coefficient at two-wavelengths: at 350 nm 
(εCORM-NBD = 10800, εproduct = 6290) and 480 nm (εCORM-NBD = 870, εproduct = 22000). φ had values of 
8.0%, 7.7%, 3.5%, and 1.2% at 350, 413, 450, and 490 nm, respectively. [230] 
6.4.2. Synthesis and measurements 






Di-(2-picolyl)amine (200 mg, 1.0 mmol) and 4-chloro-7-nitrobenzofurazan (200 mg, 1.0 mmol) 
were dissolved in 20 mL of fresh ethyl acetate. The reaction mixture was stirring for 5 h at room 
temperature. By monitoring the TLC, reaction was stopped. The crude mixture was concentrated 
and subjected to alumina column chromatographic (eluent ethyl acetate and n-hexane in 1:1(v/v)) 
purification to result pure oil compound L (158mg, 41%) after evaporation of the solvent. 
1H NMR (400 MHz, CDCl3), δ (ppm): 8.57 (2H, d, J = 4.4 Hz, ArH); 8.38 (1H, J = 8.8 Hz, ArH); 
7.70 (2H, td, J = 8.0 Hz, ArH); 7.33 (2H, d, J = 8.0 Hz, ArH); 7.27–7.23 (2H, m, ArH); 6.35 (1H, 
d, J = 9.2 Hz, ArH); 5.44 (4H, s, CH2). 13C NMR (100 MHz, CDCl3), δ (ppm): 155, 149, 145, 144, 
144, 137, 135, 123, 121, 103 and 58. ESI-MS (m/z) calculated for C18H14N6O3: 362.1, observed: 
385.0 [L + Na+].  
Synthesis of [MnL(CO)3](CF3SO3), CORM-NBD.  
In the dark and under a nitrogen atmosphere, Mn(CO)5Br (123 mg, 0.414 mmol) and silver triflate 
(106 mg, 0.414 mmol) were dissolved in 18 mL of dry acetone. The reaction mixture was stirred 
at 60 °C for 1.5 h. The reaction mixture was filtered under an inert atmosphere to separate the 
precipitate of silver bromide. To the filtrate, ligand L (150 mg, 0.414 mmol) in 10 mL of dry and 
deoxygenated acetone was added and the reaction mixture was heated under reflux for 60 °C for 
1.5 h. The reaction mixture was filtered off and washed with dry diethyl ether several times to get 
pure CORM-NBD as in dark red solid (161mg, 60%). Slow diffusion of ether into a CHCl3 
solution of CORM-NBD afforded orange red plate-like crystals suitable for X-ray studies.  
1H NMR (400 MHz, CD3CN), δ (ppm)]: 8.98 (2H, d, J = 5.6 Hz, ArH); 8.71 (1H, d, J = 8.0 Hz, 
ArH); 8.08 (2H, t, J = 7.66 Hz, ArH); 7.81 (1H, d, J = 8.0 Hz, ArH); 7.61 (4H, t, J = 4.8 Hz, ArH); 
5.61 (2H, d, J = 16.8 Hz, -CH2); 4.90 (2H, d, J = 16.8 Hz, -CH2). 13C-NMR (100 MHz, CD3CN), 
δ (ppm): 159, 152, 146, 146, 144, 140, 132, 126, 123, 115 and 66. ESI-MS (m/z) 
C22H17F3MnN6O9S, calculated for 649.99, observed: 501.0 [(CORM-NBD)--OSO2CF3]. 
IR: (ATR)ν = 2042 cm−1, 1956 cm−1 and 1933 cm−1 (νCO stretchings). Elemental analysis 
C30H26F3MnN6O8S2, calculated for C = 40.63%, H = 2.17 %, F = 8.76%, Mn = 8.45%, N = 




12.92%, O = 22.14%, S = 21.51%, found: C = 40.32%, H = 2.25%, N = 12.35%, S = 4.41%. 
Crystal Data for CORM-NBD:  
C22H14F3MnN6O9S [*], Mr = 650.39 g mol-1 [*], yellow prism, size 0.088 × 0.082 × 0.068 mm3, 
monoclinic, space group C2/c, a = 24.7020(5), b = 14.8232(3), c = 15.4917(3) Å,  = 118.287(1)°, V 
= 4995.10(17) Å3 , T= -140 °C, Z = 8, calcd. = 1.730 g cm-3, µ (Mo-K) =  7.01 cm-1, multi-scan, 
transmin: 0.7099, transmax: 0.7456, F(000) = 2624, 16444 reflections in h(-32/31), k(-19/18), l(-
17/20), measured in the range 2.51°    27.45°, completeness max = 98.8%, 5646 
independent reflections, Rint = 0.0483, 4779 reflections with Fo > 4(Fo), 435 parameters, 0 
restraints, R1obs = 0.0416, wR2obs = 0.0792, R1all = 0.0527, wR2all = 0.0849, GOOF = 1.074, 






In this present work, a collection of transition metal based nitric oxide releasing molecules 
(NORM) and carbon monoxide releasing molecules (CORM) are introduced. The first chapter 
focuses on a series of ruthenium complexes with fluorinated carboxamide ligands {Ru-NO}6. 
This conjugation ligand promoted NO liberation and improved residues stability after irradiation. 
Substituted fluorine ions worked as withdrawing functional group to influence the electron 
density of π-electrons. The two together contributed to improve the photolysis of NO from Ru(6-
Fbpb)(NO)Cl, in which substitution of fluorine occurred at the ortho position of the aromatic ring. 
Different photochemical activities of NORMs upon low intensity irradiation were performed by a 
fluorescence assay with the presence of dye NO550. DFT and TD-DFT calculations were given to 
describe the conjugation of ruthenium nitrosyls and investigate the NO release mechanism.   
In the second part of work, a similar series of ruthenium-based CO releasing molecules with 
identical ligands of ruthenium nitrosyls were synthesized. Ortho-substituted compound, Ru(6-
bpb)(CO)(H2O) demonstrated high stability under aerobic conditions as well as in solution 
environment. It released CO upon illumination with low intensity light at 405 nm with detectable 
19F NMR characteristic signal change. DFT calculations confirmed the photolysis of CO from 
Ru(6-bpb)(CO)(H2O) started from the admixture of d orbitals of metal center and antibonding π 
orbitals of ligands.  
The third section described a stable and water-soluble manganese-based tricarbonyl complex with 
a fluorobenzenesulfonyl group. This CORM-FBS was found to rapidly release almost all three 
CO molecules upon illumination with low intensity light monitored by time-dependent liquid IR 
spectroscopy. DFT and TD-DFT calculations gave insight into the CO release mechanism and the 
properties of the inactive photo-product. For the first time, 19F NMR was performed to monitor 
the photoreaction process of CORM-FBS under irradiation. The comparison of characteristic 
spectra revealed that one CO ligand was firstly photochemically dissociated and replaced by 





Then, a stable and water-soluble CORM-Dabsyl that released three CO molecules upon 
photolysis with an obviously visible colorimetric response was synthesized. DFT and TD-DFT 
calculations were performed to investigate the CO release mechanism, contribution of dabsyl 
ligand and the properties of the photo-product iCORM-Dabsyl. Furthermore, paper strips which 
loaded CORM-Dabsyl that acted as a CO-releasing material for convenient and efficient CO-
release under illumination were the first time fabricated. This process was recorded by a portable 
CO sensor (Dräger Pac7000) and its strong colorimetric response offered a direct visible 
estimation of CO release.  
The last chapter presented a colorimetric as well as fluorometric dual response CORM-NBD that 
released all three CO molecules upon photolysis at low energy light. The easily observed 
colorimetric response also provided a directly visible estimation of CO release by the naked eye. 
The turn-on luminescence made it possible to track the CO delivery within the cells from the 
cellular imaging experiments on LX-2 cells and HepaRG® cells. DFT and TD-DFT calculations 
were studied to investigate the CO release mechanism. Moreover, TLC plate sticks that loaded 
CORM-NBD achieved to release CO immediately upon irradiation with strong colorimetric 
response.  
In summary, the introduction of electron withdrawing groups and colorimetric groups aimed at 
improving the NO and CO releasing properties and render the light-triggered NORMs and 
CORMs applicable to medical situations where exogenous nitric oxide and carbon monoxide gas 
molecules are needed as drugs. These modifications are highly useful for to achieve precise 
spatial and temporal control over gas releasing as well as to monitor the photo-reaction process. 
Moreover, cell studies further confirmed the practicability of potential therapeutic agent in 
biological systems. It is reasonable to believe that the synthesis of these photo-NORMs and -






In der vorliegenden Arbeit wird eine Sammlung von übergangsmetallbasierten, 
Stickstoffmonoxidfreisetzenden- (NORM) und Kohlenstoffmonoxidfreisetzenden (CORM) 
Molekülen vorgestellt.  
Das erste Kapitel handelt von Ruthenium-Komplexen mit fluorinierten Carboxamid-Liganden 
{Ru-NO}6. Diese konjugierten Liganden fördern die NO-Freisetzung durch Lichtbestrahlung und 
verbessern die Stabilität des Komplexes nach der Bestrahlung. Durch die Substitution mit Fluor 
am Carboxamid-Liganden erhöht sich der Einfluss auf die Elektronendichte des Moleküls, da 
Fluor eine elektronenziehende Wirkung auf das π-System hat. Die zwei zusammen trugen dazu 
bei, die Photolyse von NO aus Ru(6-Fbpb)(NO)Cl zu verbessern, bei der die Substitution von 
Fluor an der ortho-Position des aromatischen Rings erfolgte. Verschiedene photochemische 
Aktivitäten der NORMs bei Bestrahlung mit geringer Intensität wurden durch einen 
Fluoreszenztest mit dem Farbstoff NO550 durchgeführt. DFT- und TD-DFT-Rechnungen wurden 
zur Beschreibung der Konjugation von Rutheniumnitrosylen und zur Untersuchung des NO-
Freisetzungsmechanismus durchgeführt. 
Im zweiten Teil der Dissertation geht es ebenfalls um Ruthenium-Carboxamid-Komplexe, 
diesmal jedoch mit einem Kohlenstoffdioxid-Liganden statt einem Nitrosyl-Liganden. Der ortho-
substituierte Komplex, Ru(6-bpb)(CO)(H2O), zeigt eine hohe Stabilität unter aeroben 
Bedingungen sowie in einer Lösungsumgebung. Durch die Bestrahlung mit Licht geringer 
Intensität bei 405 nm wird CO freigesetzt und eine mit 19F-NMR detektierbare Signaländerung 
kann gemessen werden. DFT-Rechnungen bestätigten die Photolyse von CO aus Ru(6-
bpb)(CO)(H2O), die aus der Überlappung von d-Orbitalen des Metallzentrums und der 
antibindenden π-Orbitale des Liganden resultieren. 
Der dritte Abschnitt beschreibt einen stabilen und wasserlöslichen Tricarbonylkomplex auf 
Manganbasis mit einer Fluorbenzolsulfonylgruppe (FBS). Es wurde festgestellt, dass dieses 
CORM-FBS bei Bestrahlung mit Licht niedriger Intensität alle drei CO-Moleküle fast zeitgleich 





DFT- und TD-DFT-Rechnungen lieferten Einblicke in den CO-Freisetzungsmechanismus und die 
Eigenschaften des inaktiven Fotoprodukts. Zum ersten Mal wurde 19F-NMR zur Überwachung 
des Photoreaktionsprozesses eines CORM-FBS eingesetzt. Der Vergleich der charakteristischen 
Spektren ergab, dass ein CO-Ligand zuerst photochemisch dissoziiert und durch ein 
Lösungsmittelmolekül ersetzt wurde. Weitere CO-Freisetzungen erfolgen durch 
Oxidationsreaktionen. 
Dann wurde ein stabiles und wasserlösliches CORM-Dabsyl synthetisiert, dass bei der Photolyse 
drei CO-Moleküle mit einer sichtbaren kolorimetrischen Reaktion freisetzte. DFT- und TD-DFT-
Rechnungen wurden durchgeführt, um den CO-Freisetzungsmechanismus, den Beitrag des 
Dabsyl-Liganden und die Eigenschaften des Fotoprodukts iCORM-Dabsyl zu untersuchen. 
Darüber hinaus wurden das erste mal Papierstreifen mit CORM-Dabsyl als CO-freisetzendes 
Material beladen, um eine bequeme und effiziente CO-Freisetzung durch Beleuchtung zu 
ermöglichen. Dieser Prozess wurde mit Hilfe eines tragbaren CO-Sensors (Dräger Pac7000) 
begleitet und aufgezeichnet und seine starke kolorimetrische Reaktion bot eine direkte sichtbare 
Abschätzung der CO-Freisetzung. 
Das letzte Kapitel zeigt eine Kombination aus kolorimetrischen und fluorimetrischen Reaktionen, 
CORM-NBD, welches alle drei CO-Moleküle bei der Photolyse mit energiearmen Licht freisetzte. 
Die leicht zu beobachtende kolorimetrische Reaktion lieferte auch eine direkte sichtbare 
Abschätzung der CO-Freisetzung mit bloßem Auge. Die einschaltbare Lumineszenz ermöglichte 
die Verfolgung der CO-Abgabe innerhalb der Zellen aus den zellulären Bildgebungsexperimenten 
an LX-2-Zellen und HepaRG®-Zellen. Mit Hilfe von DFT- und TD-DFT-Rechnungen wurde 
versucht den CO-Freisetzungsmechanismus zu untersuchen. Darüber hinaus wurden DC-Platten 
mit CORM-NBD geladen, um unmittelbar nach der Bestrahlung CO freizusetzen und eine starke 
kolorimetrische Rückmeldung zu erhalten. 
Zusammengefasst, die Einführung von elektronenziehenden und kolorimetrischen Gruppen 
verbessert die NO- und CO-freisetzenden Eigenschaften und macht die lichtgesteuerten NORMs 
und CORMs für medizinische Anwendungen einsetzbar, in denen exogene Stickstoffmonoxid- 
und Kohlenstoffmonoxid-Gasmoleküle als Arzneimittel benötigt werden. Diese Modifikationen 





erreichen und den Fotoreaktionsprozess zu überwachen. Darüber hinaus bestätigten Zellstudien 
die Praktikabilität potentieller Therapeutika in biologischen Systemen. Es ist anzunehmen, dass 
die Synthese dieser Photo-NORMs und -CORMs ein großer Schritt für eine nächste Generation 
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